Stimulation	O
of	O
neutrophil	B-cell_type
interleukin-8	B-protein
production	O
by	O
eosinophil	B-protein
granule	I-protein
major	I-protein
basic	I-protein
protein	I-protein
.	O

We	O
evaluated	O
the	O
ability	O
of	O
eosinophil	B-protein
granule	I-protein
major	I-protein
basic	I-protein
protein	I-protein
(	O
MBP	B-protein
)	O
to	O
stimulate	O
interleukin	B-protein
(	I-protein
IL	I-protein
)	I-protein
-8	I-protein
production	O
by	O
neutrophils	B-cell_type
.	O

MBP	B-protein
over	O
the	O
concentration	O
range	O
of	O
0.1	O
to	O
10	O
microM	O
stimulated	O
the	O
release	O
of	O
up	O
to	O
approximately	O
8	O
ng/ml	O
IL-8	B-protein
.	O

Incubation	O
with	O
2	O
microM	O
MBP	B-protein
showed	O
that	O
,	O
after	O
a	O
1	O
h	O
lag	O
,	O
the	O
level	O
of	O
IL-8	B-protein
release	O
increased	O
with	O
time	O
for	O
approximately	O
10	O
h	O
.	O

At	O
the	O
2	O
microM	O
concentration	O
,	O
eosinophil	B-protein
cationic	I-protein
protein	I-protein
,	O
eosinophil-derived	O
neurotoxin	O
,	O
and	O
eosinophil	B-protein
peroxidase	I-protein
did	O
not	O
stimulate	O
significant	O
levels	O
of	O
IL-8	B-protein
production	O
.	O

MBP	B-protein
stimulated	O
2-fold	O
increases	O
in	O
IL-8	B-RNA
messenger	I-RNA
RNA	I-RNA
(	O
mRNA	B-RNA
)	O
after	O
1	O
and	O
3	O
h	O
of	O
incubation	O
,	O
which	O
were	O
blocked	O
by	O
pretreatment	O
with	O
actinomycin	O
D	O
.	O

However	O
,	O
stimulation	O
with	O
MBP	B-protein
did	O
not	O
produce	O
an	O
increase	O
in	O
the	O
binding	O
activity	O
of	O
nuclear	B-protein
factor	I-protein
(	I-protein
NF	I-protein
)	I-protein
-kappaB	I-protein
or	O
activator	B-protein
protein-1	I-protein
.	O

No	O
NF-IL-6	B-protein
binding	O
activity	O
was	O
detected	O
in	O
the	O
same	O
nuclear	O
extracts	O
.	O

In	O
addition	O
,	O
stimulation	O
with	O
MBP	B-protein
prolonged	O
the	O
stability	O
of	O
IL-8	B-RNA
mRNA	I-RNA
.	O

MBP	B-protein
also	O
induced	O
transient	O
increases	O
in	O
mRNA	B-RNA
for	O
macrophage	B-protein
inflammatory	I-protein
protein	I-protein
(	I-protein
MIP	I-protein
)	I-protein
-1alpha	I-protein
and	O
MIP-1beta	B-protein
,	O
but	O
did	O
not	O
stimulate	O
the	O
release	O
of	O
either	O
chemokine	B-protein
.	O

These	O
findings	O
indicate	O
that	O
MBP	B-protein
is	O
selective	O
among	O
the	O
eosinophil	B-protein
granule	I-protein
proteins	I-protein
as	O
a	O
stimulus	O
for	O
neutrophil	B-cell_type
IL-8	B-protein
release	O
and	O
,	O
further	O
,	O
that	O
stimulation	O
of	O
neutrophil	B-cell_type
IL-8	B-protein
release	O
by	O
MBP	B-protein
involves	O
both	O
transcriptional	O
and	O
posttranscriptional	O
regulation	O
.	O

We	O
postulate	O
that	O
MBP	B-protein
-induced	O
release	O
of	O
IL-8	B-protein
by	O
neutrophils	B-cell_type
may	O
contribute	O
to	O
the	O
pathophysiology	O
of	O
acute	O
asthma	O
and	O
other	O
inflammatory	O
lung	O
diseases	O
.	O

Stimulation	NULL
of	NULL
Neutrophil	NULL
Interleukin-8	NULL
Production	NULL
by	NULL
Eosinophil	NULL
Granule	NULL
Major	NULL
Basic	NULL
Protein	NULL
Scott	NULL
M.	NULL
Page	NULL
,	NULL
Gerald	NULL
J.	NULL
Gleich	NULL
,	NULL
Kenneth	NULL
A.	NULL
Roebuck	NULL
,	NULL
and	NULL
Larry	NULL
L.	NULL
Thomas	NULL
Department	NULL
of	NULL
Immunology/Microbiology	NULL
,	NULL
Rush	NULL
Medical	NULL
College	NULL
,	NULL
Chicago	NULL
,	NULL
Illinois	NULL
;	NULL
and	NULL
Departments	NULL
of	NULL
Immunology	NULL
and	NULL
Medicine	NULL
,	NULL
Mayo	NULL
Clinic	NULL
and	NULL
Foundation	NULL
,	NULL
Rochester	NULL
,	NULL
Minnesota	NULL
We	NULL
evaluated	NULL
the	NULL
ability	NULL
of	NULL
eosinophil	NULL
granule	NULL
major	NULL
basic	NULL
protein	NULL
(	NULL
MBP	NULL
)	NULL
to	NULL
stimulate	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-8	NULL
production	NULL
by	NULL
neutrophils	NULL
.	NULL

MBP	NULL
over	NULL
the	NULL
concentration	NULL
range	NULL
of	NULL
0.1	NULL
to	NULL
10	NULL
M	NULL
stimulated	NULL
the	NULL
release	NULL
of	NULL
up	NULL
to	NULL
approximately	NULL
8	NULL
ng/ml	NULL
IL-8	NULL
.	NULL

Incubation	NULL
with	NULL
2	NULL
M	NULL
MBP	NULL
showed	NULL
that	NULL
,	NULL
after	NULL
a	NULL
1	NULL
h	NULL
lag	NULL
,	NULL
the	NULL
level	NULL
of	NULL
IL-8	NULL
release	NULL
increased	NULL
with	NULL
time	NULL
for	NULL
approximately	NULL
10	NULL
h.	NULL
At	NULL
the	NULL
2	NULL
uM	NULL
concentration	NULL
,	NULL
eosinophil	NULL
cationic	NULL
protein	NULL
,	NULL
eosinophil-derived	NULL
neurotoxin	NULL
,	NULL
and	NULL
eosinophil	NULL
peroxidase	NULL
did	NULL
not	NULL
stimulate	NULL
significant	NULL
levels	NULL
of	NULL
IL-8	NULL
production	NULL
.	NULL

MBP	NULL
stimulated	NULL
2-fold	NULL
increases	NULL
in	NULL
IL-8	NULL
messenger	NULL
RNA	NULL
(	NULL
mRNA	NULL
)	NULL
after	NULL
1	NULL
and	NULL
3	NULL
h	NULL
of	NULL
incubation	NULL
,	NULL
which	NULL
were	NULL
blocked	NULL
by	NULL
pretreatment	NULL
with	NULL
actinomycin	NULL
D.	NULL
However	NULL
,	NULL
stimulation	NULL
with	NULL
MBP	NULL
did	NULL
not	NULL
produce	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
binding	NULL
activity	NULL
of	NULL
nuclear	NULL
factor	NULL
(	NULL
NF	NULL
)	NULL
-	NULL
«	NULL
B	NULL
or	NULL
activator	NULL
protein-1	NULL
.	NULL

No	NULL
NF-IL-6	NULL
binding	NULL
activity	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
same	NULL
nuclear	NULL
extracts	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
stimulation	NULL
with	NULL
MBP	NULL
prolonged	NULL
the	NULL
stability	NULL
of	NULL
IL-8	NULL
mRNA	NULL
.	NULL

MBP	NULL
also	NULL
induced	NULL
transient	NULL
increases	NULL
in	NULL
mRNA	NULL
for	NULL
macrophage	NULL
inflammatory	NULL
protein	NULL
(	NULL
MIP	NULL
)	NULL
-1a	NULL
«	NULL
and	NULL
(	NULL
B	NULL
,	NULL
but	NULL
did	NULL
not	NULL
stimulate	NULL
the	NULL
release	NULL
of	NULL
either	NULL
chemokine	NULL
.	NULL

These	NULL
findings	NULL
indicate	NULL
that	NULL
MBP	NULL
is	NULL
selective	NULL
among	NULL
the	NULL
eosinophil	NULL
granule	NULL
proteins	NULL
as	NULL
a	NULL
stimulus	NULL
for	NULL
neutrophil	NULL
IL-8	NULL
release	NULL
and	NULL
,	NULL
further	NULL
,	NULL
that	NULL
stimulation	NULL
of	NULL
neutrophil	NULL
IL-8	NULL
release	NULL
by	NULL
MBP	NULL
involves	NULL
both	NULL
transcriptional	NULL
and	NULL
posttranscriptional	NULL
regulation	NULL
.	NULL

We	NULL
postulate	NULL
that	NULL
MBP-induced	NULL
release	NULL
of	NULL
IL-8	NULL
by	NULL
neutrophils	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
pathophysiology	NULL
of	NULL
acute	NULL
asthma	NULL
and	NULL
other	NULL
inflammatory	NULL
lung	NULL
diseases	NULL
.	NULL

Page	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
G.	NULL
J.	NULL
Gleich	NULL
,	NULL
K.	NULL
A.	NULL
Roebuck	NULL
,	NULL
and	NULL
L.	NULL
L.	NULL
Thomas	NULL
.	NULL

1999	NULL
.	NULL

Stimulation	NULL
of	NULL
neutrophil	NULL
interleukin-8	NULL
production	NULL
by	NULL
eosino-	NULL
phil	NULL
granule	NULL
major	NULL
basic	NULL
protein	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Respir	NULL
.	NULL

Cell	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

21:230-237	NULL
.	NULL

Major	NULL
basic	NULL
protein	NULL
(	NULL
MBP	NULL
)	NULL
is	NULL
a	NULL
13.9-kD	NULL
protein	NULL
localized	NULL
to	NULL
the	NULL
crystalloid	NULL
core	NULL
of	NULL
eosinophil	NULL
secondary	NULL
granules	NULL
and	NULL
implicated	NULL
in	NULL
many	NULL
of	NULL
the	NULL
proinflammatory	NULL
actions	NULL
of	NULL
eosinophils	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Through	NULL
its	NULL
many	NULL
actions	NULL
,	NULL
MBP	NULL
contributes	NULL
to	NULL
generation	NULL
of	NULL
the	NULL
inflammatory	NULL
milieu	NULL
and	NULL
to	NULL
the	NULL
airway	NULL
hyperreactivity	NULL
characteristic	NULL
of	NULL
chronic	NULL
asthma	NULL
.	NULL

Of	NULL
interest	NULL
among	NULL
the	NULL
activities	NULL
reported	NULL
for	NULL
MBP	NULL
is	NULL
its	NULL
capacity	NULL
to	NULL
activate	NULL
neutrophils	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
our	NULL
findings	NULL
that	NULL
MBP	NULL
in	NULL
concentrations	NULL
similar	NULL
to	NULL
those	NULL
detected	NULL
in	NULL
sputum	NULL
of	NULL
symptomatic	NULL
asthmatic	NULL
patients	NULL
stimulates	NULL
neutrophil	NULL
superoxide	NULL
anion	NULL
production	NULL
(	NULL
2	NULL
)	NULL
and	NULL
increases	NULL
neutrophil	NULL
(	NULL
Received	NULL
in	NULL
original	NULL
form	NULL
December	NULL
22	NULL
,	NULL
1998	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
March	NULL
3	NULL
,	NULL
1999	NULL
)	NULL
Address	NULL
correspondence	NULL
to	NULL
:	NULL
Larry	NULL
L.	NULL
Thomas	NULL
,	NULL
Ph.D.	NULL
,	NULL
Dept	NULL
.	NULL

of	NULL
Immunology/Microbiology	NULL
,	NULL
Rush	NULL
Medical	NULL
College	NULL
,	NULL
1653	NULL
West	NULL
Congress	NULL
Parkway	NULL
,	NULL
Chicago	NULL
,	NULL
IL	NULL
60612	NULL
.	NULL

E-mail	NULL
:	NULL
Ithomas2	NULL
@	NULL
rush.edu	NULL
Abbreviations	NULL
:	NULL
activator	NULL
protein	NULL
,	NULL
AP	NULL
;	NULL
[	NULL
y-Pladenosine	NULL
triphosphate	NULL
,	NULL
[	NULL
y-P	NULL
]	NULL
JATP	NULL
;	NULL
[	NULL
«	NULL
-P	NULL
]	NULL
deoxyuridine	NULL
triphosphate	NULL
,	NULL
[	NULL
«	NULL
-P	NULL
]	NULL
JUTP	NULL
;	NULL
eosinophil	NULL
cationic	NULL
protein	NULL
,	NULL
ECP	NULL
;	NULL
eosinophil-derived	NULL
neurotoxin	NULL
,	NULL
EDN	NULL
;	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
,	NULL
ELISA	NULL
;	NULL
eosinophil	NULL
peroxidase	NULL
,	NULL
EPO	NULL
;	NULL
interleukin	NULL
,	NULL
IL	NULL
;	NULL
lipopolysaccharide	NULL
,	NULL
LPS	NULL
;	NULL
macrophage	NULL
inhibitory	NULL
protein	NULL
,	NULL
MIP	NULL
;	NULL
major	NULL
basic	NULL
protein	NULL
,	NULL
MBP	NULL
;	NULL
messenger	NULL
RNA	NULL
,	NULL
mRNA	NULL
;	NULL
nuclear	NULL
factor	NULL
,	NULL
NF	NULL
;	NULL
regulated	NULL
on	NULL
activation	NULL
,	NULL
normal	NULL
T	NULL
cells	NULL
expressed	NULL
and	NULL
secreted	NULL
,	NULL
RANTES	NULL
;	NULL
RPMI	NULL
1640	NULL
containing	NULL
100	NULL
units/ml	NULL
penicillin	NULL
,	NULL
100	NULL
pg/ml	NULL
streptomycin	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
1-glu-tamine	NULL
,	NULL
RPML	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Respir	NULL
.	NULL

Cell	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

-	NULL
Vol	NULL
.	NULL

21	NULL
,	NULL
pp	NULL
.	NULL

230-237	NULL
,	NULL
1999	NULL
Internet	NULL
address	NULL
:	NULL
www.atsjournals.org	NULL
expression	NULL
of	NULL
CD11b/CD18	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Two	NULL
other	NULL
basic	NULL
proteins	NULL
present	NULL
in	NULL
eosinophil	NULL
granules	NULL
,	NULL
eosinophil	NULL
cationic	NULL
protein	NULL
(	NULL
ECP	NULL
)	NULL
and	NULL
eosinophil-derived	NULL
neurotoxin	NULL
(	NULL
EDN	NULL
)	NULL
(	NULL
1	NULL
)	NULL
,	NULL
were	NULL
without	NULL
effect	NULL
at	NULL
a	NULL
concentration	NULL
optimal	NULL
for	NULL
MBP	NULL
(	NULL
2	NULL
,	NULL
3	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
the	NULL
results	NULL
of	NULL
several	NULL
studies	NULL
have	NULL
suggested	NULL
the	NULL
involvement	NULL
of	NULL
neutrophils	NULL
in	NULL
the	NULL
pathophysiology	NULL
of	NULL
acute	NULL
asthma	NULL
.	NULL

Acute	NULL
exacerbations	NULL
of	NULL
asthma	NULL
and	NULL
status	NULL
asthmaticus	NULL
are	NULL
associated	NULL
with	NULL
increased	NULL
levels	NULL
of	NULL
neutrophils	NULL
in	NULL
sputum	NULL
and	NULL
in	NULL
bronchoalveolar	NULL
lavage	NULL
fluid	NULL
(	NULL
4-6	NULL
)	NULL
,	NULL
and	NULL
neutrophils	NULL
were	NULL
found	NULL
to	NULL
predominate	NULL
within	NULL
the	NULL
airway	NULL
submucosa	NULL
of	NULL
patients	NULL
who	NULL
died	NULL
of	NULL
a	NULL
``	NULL
sudden-onset	NULL
form	NULL
of	NULL
fatal	NULL
asthma	NULL
``	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
neutrophil	NULL
presence	NULL
in	NULL
the	NULL
airway	NULL
in	NULL
acute	NULL
asthma	NULL
is	NULL
superimposed	NULL
on	NULL
the	NULL
eosinophilia	NULL
characteristic	NULL
of	NULL
asthma	NULL
(	NULL
4-6	NULL
)	NULL
.	NULL

That	NULL
eosinophil	NULL
products	NULL
,	NULL
and	NULL
in	NULL
particular	NULL
MBP	NULL
,	NULL
may	NULL
contribute	NULL
to	NULL
neutrophil	NULL
activation	NULL
is	NULL
supported	NULL
by	NULL
two	NULL
observations	NULL
.	NULL

First	NULL
,	NULL
both	NULL
eosinophils	NULL
and	NULL
neutrophils	NULL
are	NULL
activated	NULL
during	NULL
acute	NULL
exacerbations	NULL
of	NULL
asthma	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
,	NULL
and	NULL
second	NULL
,	NULL
the	NULL
activated	NULL
neutrophils	NULL
are	NULL
localized	NULL
to	NULL
the	NULL
same	NULL
sites	NULL
as	NULL
the	NULL
activated	NULL
eosinophils	NULL
and	NULL
discharged	NULL
granule	NULL
basic	NULL
proteins	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Interleukin	NULL
(	NULL
IL	NULL
)	NULL
-8	NULL
is	NULL
a	NULL
potent	NULL
chemoattractant	NULL
and	NULL
activator	NULL
of	NULL
neutrophils	NULL
(	NULL
8-10	NULL
)	NULL
.	NULL

In	NULL
the	NULL
lungs	NULL
,	NULL
IL-8	NULL
appears	NULL
to	NULL
be	NULL
the	NULL
primary	NULL
chemoattractant	NULL
for	NULL
neutrophils	NULL
(	NULL
11	NULL
)	NULL
,	NULL
and	NULL
accordingly	NULL
is	NULL
directly	NULL
implicated	NULL
in	NULL
the	NULL
neutrophil	NULL
accumulation	NULL
that	NULL
follows	NULL
acute	NULL
respiratory	NULL
infection	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Al	NULL
Page	NULL
,	NULL
Gleich	NULL
,	NULL
Roebuck	NULL
,	NULL
et	NULL
al	NULL
.	NULL

:	NULL
Stimulation	NULL
of	NULL
Neutrophil	NULL
IL-8	NULL
Production	NULL
231	NULL
though	NULL
IL-8	NULL
is	NULL
produced	NULL
by	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
(	NULL
13	NULL
)	NULL
,	NULL
it	NULL
is	NULL
of	NULL
particular	NULL
interest	NULL
,	NULL
given	NULL
its	NULL
biologic	NULL
activity	NULL
,	NULL
that	NULL
IL-8	NULL
is	NULL
also	NULL
synthesized	NULL
and	NULL
released	NULL
by	NULL
neutrophils	NULL
in	NULL
response	NULL
to	NULL
a	NULL
number	NULL
of	NULL
inflammatory	NULL
mediators	NULL
(	NULL
14-18	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
IL-8	NULL
production	NULL
by	NULL
neutrophils	NULL
can	NULL
contribute	NULL
to	NULL
additional	NULL
neutrophil	NULL
recruitment	NULL
and	NULL
,	NULL
importantly	NULL
,	NULL
can	NULL
also	NULL
enhance	NULL
or	NULL
prolong	NULL
neutrophil	NULL
activation	NULL
in	NULL
an	NULL
autocrinelike	NULL
manner	NULL
.	NULL

Earlier	NULL
results	NULL
had	NULL
shown	NULL
that	NULL
MBP	NULL
can	NULL
stimulate	NULL
IL-8	NULL
production	NULL
by	NULL
eosinophils	NULL
in	NULL
a	NULL
transcription-dependent	NULL
manner	NULL
(	NULL
19	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
postulated	NULL
that	NULL
MBP	NULL
may	NULL
likewise	NULL
stimulate	NULL
IL-8	NULL
production	NULL
by	NULL
neutrophils	NULL
.	NULL

The	NULL
results	NULL
presented	NULL
here	NULL
confirm	NULL
this	NULL
hypothesis	NULL
and	NULL
show	NULL
that	NULL
the	NULL
MBP	NULL
acts	NULL
through	NULL
both	NULL
transcriptional	NULL
and	NULL
posttranscriptional	NULL
events	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Materials	NULL
Protamine	NULL
sulfate	NULL
,	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
(	NULL
Escherichia	NULL
coli	NULL
serotype	NULL
055	NULL
:	NULL
B5	NULL
)	NULL
,	NULL
dithiothreitol	NULL
(	NULL
DTT	NULL
)	NULL
,	NULL
leupeptin	NULL
,	NULL
aprotinin	NULL
,	NULL
pepstatin	NULL
A	NULL
,	NULL
4-	NULL
(	NULL
2-aminoethyl	NULL
)	NULL
-benzenesulfonyl	NULL
fluoride	NULL
(	NULL
AEBSF	NULL
)	NULL
,	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
(	NULL
PMSF	NULL
)	NULL
,	NULL
diiso-propyl	NULL
fluorophosphate	NULL
(	NULL
DFP	NULL
)	NULL
,	NULL
H,0	NULL
;	NULL
,	NULL
actinomycin	NULL
D	NULL
,	NULL
and	NULL
IGEPAL	NULL
CA-630	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

RPMI	NULL
1640	NULL
,	NULL
penicillin/streptomycin	NULL
,	NULL
L-glutamine	NULL
,	NULL
and	NULL
4-	NULL
(	NULL
2-hydroxyethyl	NULL
)	NULL
-1-piperazine-N'-2-ethane	NULL
sulfonic	NULL
acid	NULL
(	NULL
Hepes	NULL
)	NULL
buffer	NULL
solution	NULL
were	NULL
purchased	NULL
from	NULL
Gibco	NULL
Life	NULL
Technologies	NULL
(	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Sources	NULL
of	NULL
additional	NULL
reagents	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
14-kD	NULL
polymer	NULL
of	NULL
L-arginine	NULL
(	NULL
Miles	NULL
Scientific	NULL
,	NULL
Naperville	NULL
,	NULL
IL	NULL
)	NULL
;	NULL
lymphocyte	NULL
separation	NULL
medium	NULL
(	NULL
Mediatech	NULL
,	NULL
Hernedon	NULL
,	NULL
VA	NULL
)	NULL
;	NULL
human	NULL
serum	NULL
albumin	NULL
(	NULL
Calbiochem	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
;	NULL
[	NULL
«	NULL
-*P	NULL
]	NULL
deoxyuridine	NULL
triphosphate	NULL
(	NULL
[	NULL
«	NULL
-P	NULL
]	NULL
JUTP	NULL
)	NULL
(	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
;	NULL
and	NULL
[	NULL
y-*PJadenosine	NULL
triphosphate	NULL
(	NULL
[	NULL
y-P	NULL
]	NULL
ATP	NULL
)	NULL
(	NULL
An-dotek	NULL
,	NULL
Irvine	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

A	NULL
specific	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
(	NULL
ELISA	NULL
)	NULL
for	NULL
IL-8	NULL
was	NULL
purchased	NULL
from	NULL
Bio-source	NULL
International	NULL
(	NULL
Camarillo	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
specific	NULL
ELISA	NULL
s	NULL
for	NULL
macrophage	NULL
inflammatory	NULL
protein	NULL
(	NULL
MIP	NULL
)	NULL
-1a	NULL
and	NULL
MIP-1B	NULL
were	NULL
purchased	NULL
from	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
(	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
.	NULL

Oligonucleotides	NULL
corresponding	NULL
to	NULL
consensus	NULL
binding	NULL
sites	NULL
for	NULL
nuclear	NULL
factor	NULL
activator	NULL
protein	NULL
(	NULL
AP	NULL
)	NULL
-1	NULL
,	NULL
AP-2	NULL
,	NULL
and	NULL
Oct-1	NULL
were	NULL
purchased	NULL
from	NULL
Promega	NULL
(	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

An	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
consensus	NULL
binding	NULL
site	NULL
for	NULL
NF-IL-6	NULL
was	NULL
generously	NULL
provided	NULL
by	NULL
Dr.	NULL
Steven	NULL
Ackerman	NULL
(	NULL
University	NULL
of	NULL
Illinois	NULL
at	NULL
Chicago	NULL
)	NULL
.	NULL

Eosinophil	NULL
Granule	NULL
Proteins	NULL
MBP	NULL
,	NULL
ECP	NULL
,	NULL
EDN	NULL
,	NULL
and	NULL
eosinophil	NULL
peroxidase	NULL
(	NULL
EPO	NULL
)	NULL
were	NULL
isolated	NULL
as	NULL
described	NULL
previously	NULL
from	NULL
eosinophils	NULL
of	NULL
patients	NULL
with	NULL
the	NULL
hypereosinophlic	NULL
syndrome	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
pure	NULL
as	NULL
judged	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
and	NULL
staining	NULL
with	NULL
Coomassie	NULL
brilliant	NULL
blue	NULL
R	NULL
250	NULL
.	NULL

The	NULL
EPO	NULL
was	NULL
enzymatically	NULL
active	NULL
as	NULL
determined	NULL
with	NULL
a	NULL
previously	NULL
described	NULL
method	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Endotoxin	NULL
content	NULL
in	NULL
the	NULL
granule	NULL
proteins	NULL
was	NULL
measured	NULL
with	NULL
the	NULL
L	NULL
imulus	NULL
amebocyte	NULL
lysate	NULL
assay	NULL
(	NULL
Associates	NULL
of	NULL
Cape	NULL
Cod	NULL
,	NULL
Falmouth	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Neutrophil	NULL
Isolation	NULL
Neutrophils	NULL
were	NULL
isolated	NULL
under	NULL
sterile	NULL
conditions	NULL
from	NULL
the	NULL
venous	NULL
blood	NULL
of	NULL
healthy	NULL
adult	NULL
volunteers	NULL
through	NULL
den	NULL
sity	NULL
gradient	NULL
centrifugation	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
23	NULL
)	NULL
.	NULL

The	NULL
neutrophils	NULL
were	NULL
resuspended	NULL
in	NULL
RPMI	NULL
1640	NULL
containing	NULL
100	NULL
U/ml	NULL
!	NULL

penicillin	NULL
,	NULL
100	NULL
g/m	NULL
!	NULL

streptomycin	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
L-glutamine	NULL
(	NULL
RPMI	NULL
)	NULL
.	NULL

Incubation	NULL
Conditions	NULL
for	NULL
Measurement	NULL
of	NULL
Chemokine	NULL
Release	NULL
Neutrophils	NULL
(	NULL
108	NULL
cells	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
stimuli	NULL
in	NULL
RPMI	NULL
containing	NULL
10	NULL
%	NULL
heat-inactivated	NULL
(	NULL
56°C	NULL
;	NULL
45	NULL
min	NULL
)	NULL
autologous	NULL
serum	NULL
(	NULL
added	NULL
separately	NULL
to	NULL
the	NULL
incubation	NULL
con-tents	NULL
)	NULL
in	NULL
24-well	NULL
tissue	NULL
culture	NULL
plates	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
atmosphere	NULL
.	NULL

Spontaneous	NULL
IL-8	NULL
production	NULL
was	NULL
determined	NULL
with	NULL
cells	NULL
incubated	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
stimulus	NULL
,	NULL
and	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
MBP	NULL
vehicle	NULL
buffer	NULL
(	NULL
25	NULL
mM	NULL
sodium	NULL
acetate	NULL
,	NULL
150	NULL
mM	NULL
sodium	NULL
chloride	NULL
,	NULL
pH	NULL
4.3	NULL
)	NULL
was	NULL
examined	NULL
by	NULL
addition	NULL
of	NULL
the	NULL
buffer	NULL
in	NULL
the	NULL
same	NULL
volumes	NULL
as	NULL
required	NULL
for	NULL
MBP	NULL
addi-tion	NULL
.	NULL

Total	NULL
incubation	NULL
volume	NULL
was	NULL
0.5	NULL
ml	NULL
.	NULL

The	NULL
reactions	NULL
were	NULL
terminated	NULL
by	NULL
centrifugation	NULL
at	NULL
400	NULL
X	NULL
g	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
and	NULL
the	NULL
cell-free	NULL
supernatants	NULL
were	NULL
stored	NULL
at	NULL
-20°C	NULL
until	NULL
the	NULL
levels	NULL
of	NULL
IL-8	NULL
,	NULL
MIP-1	NULL
«	NULL
,	NULL
and	NULL
MIP-1B	NULL
were	NULL
measured	NULL
with	NULL
a	NULL
specific	NULL
ELISA	NULL
.	NULL

Ribonuclease	NULL
Protection	NULL
Assay	NULL
Neutrophils	NULL
(	NULL
10	NULL
'	NULL
cells/ml	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
MBP	NULL
or	NULL
LPS	NULL
in	NULL
RPMI	NULL
supplemented	NULL
with	NULL
10	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
and	NULL
containing	NULL
10	NULL
%	NULL
heat-inactivated	NULL
autologous	NULL
serum	NULL
in	NULL
15-ml	NULL
round-bottom	NULL
polypropylene	NULL
tubes	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
at	NULL
37°C	NULL
in	NULL
an	NULL
oscillating	NULL
water	NULL
bath	NULL
.	NULL

Total	NULL
incubation	NULL
volume	NULL
was	NULL
2	NULL
ml	NULL
.	NULL

For	NULL
some	NULL
samples	NULL
,	NULL
actinomycin	NULL
D	NULL
(	NULL
5	NULL
g/	NULL
ml	NULL
)	NULL
was	NULL
added	NULL
1	NULL
h	NULL
before	NULL
or	NULL
after	NULL
incubation	NULL
with	NULL
the	NULL
stim-uli	NULL
,	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
text	NULL
.	NULL

The	NULL
reactions	NULL
were	NULL
terminated	NULL
by	NULL
centrifugation	NULL
at	NULL
300	NULL
X	NULL
g	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
cell	NULL
pellets	NULL
were	NULL
washed	NULL
once	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
at	NULL
4°C	NULL
,	NULL
and	NULL
total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
2	NULL
X	NULL
10	NULL
``	NULL
neutrophils	NULL
using	NULL
Trizol	NULL
reagent	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

For	NULL
the	NULL
ribonuclease	NULL
(	NULL
RNase	NULL
)	NULL
protection	NULL
assay	NULL
,	NULL
we	NULL
used	NULL
the	NULL
RiboQuant	NULL
multiprobe	NULL
RNase	NULL
protection	NULL
assay	NULL
(	NULL
hCK-5	NULL
;	NULL
PharMingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
complementary	NULL
DNA	NULL
(	NULL
cDNA	NULL
)	NULL
probes	NULL
were	NULL
radiolabeled	NULL
with	NULL
[	NULL
«	NULL
-P	NULL
]	NULL
UTP	NULL
,	NULL
and	NULL
the	NULL
assay	NULL
was	NULL
performed	NULL
exactly	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Positive	NULL
messenger	NULL
RNA	NULL
(	NULL
mRNA	NULL
)	NULL
bands	NULL
were	NULL
quantified	NULL
densitometrically	NULL
using	NULL
a	NULL
STORM	NULL
phosphorimager	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
mRNA	NULL
levels	NULL
of	NULL
the	NULL
chemokines	NULL
were	NULL
normalized	NULL
to	NULL
that	NULL
of	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
Neutrophils	NULL
(	NULL
10	NULL
'	NULL
cells/ml	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
MBP	NULL
,	NULL
EDN	NULL
,	NULL
or	NULL
LPS	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
74	NULL
,	NULL
in	NULL
15-ml	NULL
round-bottom	NULL
polypropylene	NULL
tubes	NULL
for	NULL
20	NULL
min	NULL
or	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

Total	NULL
incubation	NULL
volume	NULL
was	NULL
1	NULL
ml	NULL
.	NULL

The	NULL
reactions	NULL
were	NULL
stopped	NULL
by	NULL
transfer	NULL
of	NULL
the	NULL
mixtures	NULL
to	NULL
microcentrifuge	NULL
tubes	NULL
and	NULL
centrifugation	NULL
at	NULL
300	NULL
X	NULL
g	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
the	NULL
cell	NULL
pellets	NULL
as	NULL
described	NULL
by	NULL
Osborn	NULL
and	NULL
colleagues	NULL
(	NULL
25	NULL
)	NULL
using	NULL
a	NULL
modification	NULL
of	NULL
the	NULL
protease	NULL
inhibitor	NULL
cocktail	NULL
described	NULL
by	NULL
McDonald	NULL
and	NULL
coworkers	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
ice-cold	NULL
Buffer	NULL
A	NULL
{	NULL
10	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.9	NULL
;	NULL
1.5	NULL
mM	NULL
MgCl	NULL
)	NULL
;	NULL
;	NULL
10	NULL
mM	NULL
KCl	NULL
;	NULL
and	NULL
0.5	NULL
mM	NULL
DTT	NULL
)	NULL
containing	NULL
a	NULL
protease	NULL
inhibitor	NULL
cocktail	NULL
(	NULL
4	NULL
mM	NULL
232	NULL
AMERICAN	NULL
JOURNAL	NULL
OF	NULL
RESPIRATORY	NULL
CELL	NULL
AND	NULL
MOLECULAR	NULL
BIOLOGY	NULL
VOL	NULL
.	NULL

21	NULL
1999	NULL
12000	NULL
10000	NULL
|	NULL
IL-8	NULL
&	NULL
8	NULL
I	NULL
4000	NULL
|	NULL
2000	NULL
|	NULL
4.1	NULL
1	NULL
10	NULL
MBP	NULL
fuk	NULL
)	NULL
Figure	NULL
1	NULL
.	NULL

Concentration	NULL
requirements	NULL
for	NULL
MBP-stimulated	NULL
IL-8	NULL
release	NULL
.	NULL

Neutrophils	NULL
(	NULL
2	NULL
X	NULL
10	NULL
%	NULL
/ml	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
MBP	NULL
for	NULL
18	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
net	NULL
amount	NULL
of	NULL
IL-8	NULL
release	NULL
is	NULL
given	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
for	NULL
three	NULL
to	NULL
five	NULL
experiments	NULL
.	NULL

Spontaneous	NULL
IL-8	NULL
production	NULL
was	NULL
85	NULL
+	NULL
63	NULL
pg/ml	NULL
.	NULL

The	NULL
MBP	NULL
vehicle	NULL
buffer	NULL
in	NULL
volumes	NULL
required	NULL
for	NULL
the	NULL
MBP	NULL
addition	NULL
did	NULL
not	NULL
stimulate	NULL
any	NULL
IL-8	NULL
release	NULL
.	NULL

The	NULL
MBP	NULL
did	NULL
not	NULL
interfere	NULL
with	NULL
the	NULL
measurement	NULL
of	NULL
IL-8	NULL
.	NULL

(	NULL
*P	NULL
<	NULL
0.05	NULL
compared	NULL
with	NULL
spontaneous	NULL
value	NULL
by	NULL
ANOVA	NULL
.	NULL
)	NULL

DFP	NULL
,	NULL
2	NULL
mM	NULL
each	NULL
of	NULL
PMSF	NULL
and	NULL
AEBSF	NULL
,	NULL
and	NULL
10	NULL
pg/ml	NULL
each	NULL
of	NULL
leupeptin	NULL
,	NULL
aprotinin	NULL
,	NULL
and	NULL
pepstatin	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
collected	NULL
between	NULL
washes	NULL
by	NULL
centrifugation	NULL
at	NULL
300	NULL
X	NULL
g	NULL
for	NULL
5	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
cell	NULL
pellets	NULL
were	NULL
resuspended	NULL
in	NULL
ice-cold	NULL
Buffer	NULL
A	NULL
(	NULL
and	NULL
protease	NULL
inhibitor	NULL
cocktail	NULL
)	NULL
containing	NULL
0.1	NULL
%	NULL
of	NULL
the	NULL
nonionic	NULL
detergent	NULL
IGEPAL	NULL
CA-630	NULL
,	NULL
and	NULL
were	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
min	NULL
.	NULL

The	NULL
nuclei	NULL
were	NULL
pelleted	NULL
by	NULL
centrifugation	NULL
at	NULL
12,000	NULL
X	NULL
g	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
and	NULL
were	NULL
resuspended	NULL
in	NULL
15	NULL
pl	NULL
of	NULL
ice-cold	NULL
Buffer	NULL
C	NULL
(	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.9	NULL
;	NULL
25	NULL
%	NULL
glycerol	NULL
;	NULL
420	NULL
mM	NULL
NaCI	NULL
;	NULL
1.5	NULL
mM	NULL
MgCl	NULL
;	NULL
;	NULL
0.5	NULL
mM	NULL
ethylenediaminetetraacetic	NULL
acid	NULL
[	NULL
EDTA	NULL
]	NULL
;	NULL
and	NULL
0.5	NULL
mM	NULL
DTT	NULL
)	NULL
containing	NULL
the	NULL
protease	NULL
inhibitor	NULL
cocktail	NULL
.	NULL

The	NULL
nuclei	NULL
were	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
and	NULL
,	NULL
after	NULL
centrifugation	NULL
at	NULL
12,000	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
the	NULL
supernatants	NULL
were	NULL
transferred	NULL
to	NULL
a	NULL
new	NULL
microcentrifuge	NULL
tube	NULL
containing	NULL
30	NULL
pl	NULL
1200	NULL
1004	NULL
|-	NULL
*	NULL
__	NULL
soo	NULL
|-€	NULL
o	NULL
A	NULL
sx	NULL
|-=	NULL
9	NULL
=	NULL
400	NULL
|-2m	NULL
|-	NULL
,	NULL
o	NULL
\a	NULL
1	NULL
1	NULL
1	NULL
1	NULL
a	NULL
5	NULL
10	NULL
1s	NULL
20	NULL
Timé	NULL
thr	NULL
)	NULL
Figure	NULL
2	NULL
.	NULL

Time	NULL
course	NULL
for	NULL
MBP-stimulated	NULL
IL-8	NULL
release	NULL
.	NULL

Neutrophils	NULL
(	NULL
2	NULL
X	NULL
10®/ml	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
2	NULL
uM	NULL
MBP	NULL
for	NULL
2	NULL
,	NULL
5	NULL
,	NULL
10	NULL
,	NULL
and	NULL
20	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
net	NULL
IL-8	NULL
release	NULL
at	NULL
each	NULL
time	NULL
point	NULL
is	NULL
given	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
for	NULL
four	NULL
experiments	NULL
.	NULL

Spontaneous	NULL
IL-8	NULL
release	NULL
was	NULL
undetectable	NULL
at	NULL
1	NULL
and	NULL
2	NULL
h	NULL
,	NULL
and	NULL
was	NULL
71	NULL
+	NULL
37	NULL
pg/ml	NULL
,	NULL
124	NULL
+	NULL
59	NULL
pg/ml	NULL
,	NULL
and	NULL
152	NULL
+	NULL
91	NULL
pg/ml	NULL
at	NULL
5	NULL
,	NULL
10	NULL
,	NULL
and	NULL
20	NULL
h	NULL
,	NULL
respectively	NULL
.	NULL

(	NULL
*P	NULL
<	NULL
0.05	NULL
compared	NULL
with	NULL
the	NULL
spontaneous	NULL
value	NULL
at	NULL
the	NULL
same	NULL
time	NULL
point	NULL
by	NULL
the	NULL
paired	NULL
f	NULL
test	NULL
.	NULL
)	NULL

of	NULL
ice-cold	NULL
Buffer	NULL
D	NULL
(	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.9	NULL
;	NULL
20	NULL
%	NULL
glycerol	NULL
;	NULL
50	NULL
mM	NULL
KCI	NULL
;	NULL
0.5	NULL
mM	NULL
EDTA	NULL
;	NULL
and	NULL
0.5	NULL
mM	NULL
DTT	NULL
)	NULL
with	NULL
the	NULL
protease	NULL
inhibitor	NULL
cocktail	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
stored	NULL
in	NULL
ali-quots	NULL
at	NULL
-70°C	NULL
until	NULL
analysis	NULL
.	NULL

Protein	NULL
concentration	NULL
was	NULL
measured	NULL
with	NULL
the	NULL
BioRad	NULL
Protein	NULL
Assay	NULL
(	NULL
BioRad	NULL
Labo-ratories	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Nuclear	NULL
proteins	NULL
(	NULL
8	NULL
wg	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
[	NULL
y-*	NULL
>	NULL
P	NULL
]	NULL
ATP-labeled	NULL
double-stranded	NULL
DNA	NULL
(	NULL
dsDNA	NULL
)	NULL
oligonucleotide	NULL
probes	NULL
(	NULL
50,000	NULL
cpm	NULL
)	NULL
corresponding	NULL
to	NULL
the	NULL
consensus	NULL
binding	NULL
sites	NULL
for	NULL
NF-kB	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
NF-IL-6	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Inhibition	NULL
of	NULL
binding	NULL
through	NULL
use	NULL
of	NULL
a	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
specific	NULL
probe	NULL
or	NULL
an	NULL
irrelevant	NULL
probe	NULL
(	NULL
AP-2	NULL
for	NULL
NF-kB	NULL
,	NULL
and	NULL
Oct-1	NULL
for	NULL
AP-1	NULL
and	NULL
NF-IL-6	NULL
)	NULL
was	NULL
evaluated	NULL
to	NULL
determine	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
detection	NULL
.	NULL

Samples	NULL
were	NULL
run	NULL
on	NULL
a	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
exposed	NULL
to	NULL
X-OMAT-AR	NULL
film	NULL
(	NULL
Eastman	NULL
Kodak	NULL
,	NULL
Rochester	NULL
,	NULL
NY	NULL
)	NULL
at	NULL
-70°C	NULL
.	NULL

Statistical	NULL
Analysis	NULL
Statistical	NULL
significance	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
paired	NULL
¢	NULL
test	NULL
or	NULL
by	NULL
analysis	NULL
of	NULL
variance	NULL
(	NULL
ANOVA	NULL
)	NULL
and	NULL
Fisher	NULL
's	NULL
protected	NULL
least	NULL
significant	NULL
differences	NULL
test	NULL
for	NULL
repeated	NULL
mea-sures	NULL
.	NULL

A	NULL
value	NULL
of	NULL
P	NULL
<	NULL
0.05	NULL
was	NULL
accepted	NULL
as	NULL
significant	NULL
.	NULL

Results	NULL
Concentration-Dependence	NULL
and	NULL
Time	NULL
Course	NULL
for	NULL
MBP-Stimulated	NULL
IL-8	NULL
Production	NULL
The	NULL
capacity	NULL
of	NULL
MBP	NULL
to	NULL
stimulate	NULL
neutrophil	NULL
IL-8	NULL
production	NULL
was	NULL
evaluated	NULL
over	NULL
the	NULL
concentration	NULL
range	NULL
of	NULL
0.1-10	NULL
M	NULL
MBP	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
1	NULL
,	NULL
incubating	NULL
neutrophils	NULL
with	NULL
0.1	NULL
jwM	NULL
or	NULL
0.3	NULL
wM	NULL
MBP	NULL
for	NULL
18	NULL
h	NULL
at	NULL
37°C	NULL
produced	NULL
negligible	NULL
IL-8	NULL
release	NULL
.	NULL

MBP	NULL
in	NULL
concentrations	NULL
of	NULL
1-10	NULL
pM	NULL
,	NULL
however	NULL
,	NULL
stimulated	NULL
the	NULL
release	NULL
of	NULL
up	NULL
to	NULL
approximately	NULL
8	NULL
ng/ml	NULL
IL-8	NULL
in	NULL
a	NULL
concentration-dependent	NULL
manner	NULL
.	NULL

To	NULL
avoid	NULL
possible	NULL
cytotoxic	NULL
effects	NULL
that	NULL
may	NULL
be	NULL
associated	NULL
with	NULL
high	NULL
concentrations	NULL
of	NULL
MBP	NULL
(	NULL
1	NULL
)	NULL
,	NULL
the	NULL
time	NULL
course	NULL
for	NULL
MBP	NULL
-stimulated	NULL
IL-8	NULL
production	NULL
was	NULL
determined	NULL
with	NULL
2	NULL
uM	NULL
$	NULL
000	NULL
2500	NULL
2000	NULL
1500	NULL
IL-8	NULL
.	NULL

(	NULL
pgimf	NULL
}	NULL
od	NULL
MBF	NULL
ECP	NULL
EDN	NULL
E90	NULL
Prot	NULL
Poy-A	NULL
LPS	NULL
«	NULL
--	NULL
2	NULL
pd	NULL
0.9	NULL
pM	NULL
Figure	NULL
3	NULL
.	NULL

Stimulation	NULL
of	NULL
IL-8	NULL
release	NULL
by	NULL
eosinophil	NULL
granule	NULL
basic	NULL
proteins	NULL
.	NULL

Neutrophils	NULL
(	NULL
2	NULL
X	NULL
10	NULL
%	NULL
/ml	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
indicated	NULL
concentrations	NULL
of	NULL
eosinophil	NULL
granule	NULL
proteins	NULL
,	NULL
protamine	NULL
(	NULL
Prot	NULL
)	NULL
,	NULL
Poly-R	NULL
,	NULL
or	NULL
100	NULL
ng/ml	NULL
LPS	NULL
for	NULL
18	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

IL-8	NULL
release	NULL
is	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
for	NULL
four	NULL
to	NULL
eight	NULL
experiments	NULL
,	NULL
after	NULL
correction	NULL
for	NULL
spontaneous	NULL
release	NULL
.	NULL

The	NULL
level	NULL
of	NULL
spontaneous	NULL
IL-8	NULL
release	NULL
was	NULL
192	NULL
+	NULL
113	NULL
pg/ml	NULL
,	NULL
and	NULL
IL-8	NULL
release	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
MBP	NULL
vehicle	NULL
buffer	NULL
was	NULL
93	NULL
+	NULL
54	NULL
pg/ml	NULL
.	NULL

(	NULL
*P	NULL
<	NULL
0.05	NULL
compared	NULL
with	NULL
the	NULL
spontaneous	NULL
value	NULL
by	NULL
ANOVA	NULL
.	NULL
)	NULL

Page	NULL
,	NULL
Gleich	NULL
,	NULL
Roebuck	NULL
,	NULL
et	NULL
al	NULL
.	NULL

:	NULL
Stimulation	NULL
of	NULL
Neutrophil	NULL
IL-8	NULL
Production	NULL
233	NULL
MBP	NULL
.	NULL

The	NULL
results	NULL
,	NULL
in	NULL
Figure	NULL
2	NULL
,	NULL
show	NULL
that	NULL
a	NULL
statistically	NULL
significant	NULL
level	NULL
of	NULL
IL-8	NULL
release	NULL
occurred	NULL
after	NULL
2	NULL
h	NULL
of	NULL
incubation	NULL
with	NULL
MBP	NULL
,	NULL
and	NULL
that	NULL
the	NULL
level	NULL
of	NULL
MBP	NULL
-induced	NULL
IL-8	NULL
release	NULL
then	NULL
increased	NULL
with	NULL
time	NULL
for	NULL
up	NULL
to	NULL
10	NULL
h	NULL
of	NULL
incubation	NULL
.	NULL

An	NULL
additional	NULL
10	NULL
h	NULL
of	NULL
incubation	NULL
with	NULL
MBP	NULL
resulted	NULL
in	NULL
only	NULL
a	NULL
minimal	NULL
further	NULL
increase	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
IL-8	NULL
re-leased	NULL
.	NULL

Stimulation	NULL
of	NULL
Neutrophil	NULL
IL-8	NULL
Production	NULL
by	NULL
Eosinophil	NULL
Granule	NULL
Basic	NULL
Proteins	NULL
The	NULL
ability	NULL
of	NULL
the	NULL
three	NULL
other	NULL
basic	NULL
eosinophil	NULL
granule	NULL
proteins	NULL
to	NULL
likewise	NULL
stimulate	NULL
neutrophil	NULL
IL-8	NULL
production	NULL
at	NULL
a	NULL
concentration	NULL
effective	NULL
for	NULL
MBP	NULL
was	NULL
evaluated	NULL
by	NULL
incubating	NULL
neutrophils	NULL
with	NULL
2	NULL
wM	NULL
MBP	NULL
,	NULL
ECP	NULL
,	NULL
EDN	NULL
,	NULL
or	NULL
EPO	NULL
for	NULL
18	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

MBP	NULL
stimulated	NULL
the	NULL
release	NULL
of	NULL
approximately	NULL
1,800	NULL
pg/ml	NULL
IL-8	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
;	NULL
however	NULL
,	NULL
neither	NULL
ECP	NULL
nor	NULL
EDN	NULL
stimulated	NULL
IL-8	NULL
release	NULL
,	NULL
and	NULL
EPO	NULL
stimulated	NULL
the	NULL
release	NULL
of	NULL
130	NULL
pg/ml	NULL
IL-8	NULL
,	NULL
a	NULL
level	NULL
that	NULL
was	NULL
not	NULL
statistically	NULL
significant	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
40-1,000	NULL
wM	NULL
H,0	NULL
,	NULL
did	NULL
not	NULL
enhance	NULL
the	NULL
ability	NULL
of	NULL
EPO	NULL
to	NULL
stimulate	NULL
IL-8	NULL
release	NULL
,	NULL
and	NULL
EPO	NULL
was	NULL
similarly	NULL
ineffective	NULL
at	NULL
lower	NULL
concentrations	NULL
(	NULL
0.03-0.3	NULL
wM	NULL
)	NULL
reported	NULL
to	NULL
induce	NULL
shape	NULL
changes	NULL
in	NULL
neutrophils	NULL
(	NULL
27	NULL
)	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
abilities	NULL
of	NULL
a	NULL
14-kD	NULL
A	NULL
1	NULL
hr	NULL
|	NULL
3	NULL
hr	NULL
+ACt.D|	NULL
+	NULL
Act	NULL
.	NULL

D	NULL
5	NULL
ha	NULL
u	NULL
5	NULL
&	NULL
p	NULL
S	NULL
4	NULL
p	NULL
g	NULL
3	NULL
p	NULL
©	NULL
&	NULL
&	NULL
|	NULL
&	NULL
a	NULL
a	NULL
[	NULL
a	NULL
s	NULL
%	NULL
&	NULL
z	NULL
z	NULL
5	NULL
a	NULL
zs	NULL
3	NULL
MIP-1	NULL
$	NULL
»	NULL
MIP-1o	NULL
.	NULL

@	NULL
»	NULL
n	NULL
IL-8	NULL
t=	NULL
8	NULL
MIP-16	NULL
4	NULL
_	NULL
UJ	NULL
a	NULL
|	NULL
we-	NULL
--	NULL
suus	NULL
cue	NULL
8	NULL
6	NULL
.	NULL

MIP-tot	NULL
3	NULL
9	NULL
al	NULL
iS	NULL
o	NULL
fra	NULL
L.	NULL
wou	NULL
meum	NULL
wu	NULL
wae	NULL
m	NULL
*j	NULL
IL-8	NULL
2	NULL
}	NULL
CB	NULL
______	NULL
HH	NULL
___	NULL
Figure	NULL
4	NULL
.	NULL

Induction	NULL
of	NULL
chemokine	NULL
mRNA	NULL
synthesis	NULL
by	NULL
MBP	NULL
and	NULL
LPS	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Neutrophils	NULL
(	NULL
10'/ml	NULL
)	NULL
were	NULL
preincubated	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
5	NULL
ug/ml	NULL
actinomycin	NULL
D	NULL
(	NULL
Act	NULL
.	NULL

D	NULL
)	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
incubated	NULL
with	NULL
5	NULL
wM	NULL
MBP	NULL
or	NULL
1	NULL
g/ml	NULL
LPS	NULL
,	NULL
or	NULL
in	NULL
RPMI	NULL
alone	NULL
(	NULL
Spont	NULL
)	NULL
,	NULL
for	NULL
1	NULL
or	NULL
3	NULL
h.	NULL
Expression	NULL
of	NULL
IL-8	NULL
,	NULL
MIP-1	NULL
@	NULL
,	NULL
MIP-1f	NULL
,	NULL
released	NULL
on	NULL
activation	NULL
,	NULL
normal	NULL
T-cell-expressed	NULL
and	NULL
secreted	NULL
(	NULL
RANTES	NULL
)	NULL
,	NULL
MCP-1	NULL
,	NULL
IP-10	NULL
,	NULL
1-309	NULL
,	NULL
L-32	NULL
,	NULL
and	NULL
GAPDH	NULL
mRNA	NULL
was	NULL
determined	NULL
by	NULL
RNase	NULL
protection	NULL
assay	NULL
.	NULL

Only	NULL
positive	NULL
mRNA	NULL
bands	NULL
are	NULL
labeled	NULL
;	NULL
note	NULL
that	NULL
IL-8	NULL
mRNA	NULL
and	NULL
MIP-1la	NULL
mRNA	NULL
each	NULL
run	NULL
as	NULL
a	NULL
doublet	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
positive	NULL
mRNA	NULL
bands	NULL
of	NULL
the	NULL
three	NULL
chemokines	NULL
(	NULL
A	NULL
)	NULL
were	NULL
quantified	NULL
densitometrically	NULL
and	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
density	NULL
of	NULL
GAPDH	NULL
mRNA	NULL
.	NULL

The	NULL
results	NULL
are	NULL
presented	NULL
as	NULL
the	NULL
fold	NULL
increase	NULL
in	NULL
mRNA	NULL
level	NULL
for	NULL
each	NULL
of	NULL
the	NULL
three	NULL
chemokines	NULL
relative	NULL
to	NULL
the	NULL
mRNA	NULL
level	NULL
in	NULL
unstimulated	NULL
cells	NULL
(	NULL
Spont	NULL
)	NULL
.	NULL

polymer	NULL
of	NULL
L-arginine	NULL
(	NULL
Poly-R	NULL
)	NULL
and	NULL
of	NULL
protamine	NULL
,	NULL
a	NULL
4.8-kD	NULL
protein	NULL
containing	NULL
66	NULL
%	NULL
arginine	NULL
(	NULL
28	NULL
)	NULL
,	NULL
to	NULL
stimulate	NULL
IL-8	NULL
production	NULL
were	NULL
also	NULL
evaluated	NULL
in	NULL
the	NULL
same	NULL
experiments	NULL
in	NULL
order	NULL
to	NULL
further	NULL
assess	NULL
the	NULL
contribution	NULL
of	NULL
the	NULL
basic	NULL
charge	NULL
of	NULL
the	NULL
MBP	NULL
molecule	NULL
to	NULL
its	NULL
activity	NULL
.	NULL

Incubation	NULL
of	NULL
neutrophils	NULL
with	NULL
0.3	NULL
M	NULL
Poly-R	NULL
,	NULL
which	NULL
corresponds	NULL
on	NULL
a	NULL
weight	NULL
basis	NULL
to	NULL
the	NULL
arginine	NULL
content	NULL
of	NULL
2	NULL
M	NULL
MBP	NULL
(	NULL
1	NULL
)	NULL
,	NULL
or	NULL
with	NULL
2	NULL
M	NULL
protamine	NULL
,	NULL
resulted	NULL
in	NULL
the	NULL
release	NULL
of	NULL
less	NULL
than	NULL
70	NULL
pg/ml	NULL
IL-8	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

In	NULL
the	NULL
same	NULL
experiments	NULL
,	NULL
100	NULL
ng/ml	NULL
LPS	NULL
stimulated	NULL
the	NULL
release	NULL
of	NULL
1,280	NULL
pg/ml	NULL
IL-8	NULL
.	NULL

MBP-Stimulated	NULL
IL-8	NULL
Production	NULL
by	NULL
Neutrophils	NULL
Is	NULL
Independent	NULL
of	NULL
Endotoxin	NULL
As	NULL
reported	NULL
previously	NULL
by	NULL
others	NULL
(	NULL
14	NULL
)	NULL
,	NULL
and	NULL
as	NULL
shown	NULL
earlier	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
,	NULL
LPS	NULL
is	NULL
an	NULL
effective	NULL
stimulus	NULL
for	NULL
neutrophil	NULL
IL-8	NULL
production	NULL
.	NULL

Measurement	NULL
of	NULL
endotoxin	NULL
content	NULL
in	NULL
the	NULL
granule	NULL
protein	NULL
preparations	NULL
indicated	NULL
that	NULL
a	NULL
2	NULL
M	NULL
concentration	NULL
of	NULL
the	NULL
granule	NULL
proteins	NULL
contained	NULL
endotoxin	NULL
levels	NULL
of	NULL
0.1	NULL
ng/ml	NULL
(	NULL
MBP	NULL
)	NULL
,	NULL
0.8	NULL
ng/ml	NULL
(	NULL
ECP	NULL
)	NULL
,	NULL
0.7	NULL
ng/ml	NULL
(	NULL
EDN	NULL
)	NULL
,	NULL
and	NULL
1.8	NULL
ng/ml	NULL
(	NULL
EPO	NULL
)	NULL
,	NULL
which	NULL
did	NULL
not	NULL
correlate	NULL
with	NULL
the	NULL
abilities	NULL
of	NULL
the	NULL
proteins	NULL
to	NULL
stimulate	NULL
neutrophil	NULL
IL-8	NULL
production	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

Additional	NULL
results	NULL
showed	NULL
that	NULL
heating	NULL
MBP	NULL
for	NULL
5	NULL
min	NULL
at	NULL
100°C	NULL
abrogated	NULL
by	NULL
more	NULL
than	NULL
90	NULL
%	NULL
the	NULL
ability	NULL
of	NULL
2	NULL
wM	NULL
MBP	NULL
to	NULL
stimulate	NULL
IL-8	NULL
production	NULL
(	NULL
n	NULL
=	NULL
3	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
heating	NULL
did	NULL
not	NULL
reduce	NULL
the	NULL
activity	NULL
of	NULL
LPS	NULL
in	NULL
the	NULL
same	NULL
experiments	NULL
.	NULL

Induction	NULL
of	NULL
IL-8	NULL
mRNA	NULL
Synthesis	NULL
by	NULL
MBP	NULL
To	NULL
assess	NULL
the	NULL
effect	NULL
of	NULL
MBP	NULL
stimulation	NULL
on	NULL
IL-8	NULL
mRNA	NULL
synthesis	NULL
,	NULL
as	NULL
well	NULL
as	NULL
to	NULL
screen	NULL
for	NULL
the	NULL
synthesis	NULL
of	NULL
additional	NULL
chemokines	NULL
,	NULL
an	NULL
RNase	NULL
protection	NULL
assay	NULL
was	NULL
performed	NULL
after	NULL
incubating	NULL
neutrophils	NULL
with	NULL
5	NULL
wM	NULL
MBP	NULL
or	NULL
,	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
,	NULL
1	NULL
pg/ml	NULL
LPS	NULL
for	NULL
1	NULL
h	NULL
and	NULL
3	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

IL-8	NULL
mRNA	NULL
was	NULL
detected	NULL
at	NULL
1	NULL
h	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
at	NULL
3	NULL
h	NULL
in	NULL
unstimulated	NULL
neutrophils	NULL
,	NULL
but	NULL
incubation	NULL
with	NULL
MBP	NULL
produced	NULL
additional	NULL
2-fold	NULL
increases	NULL
(	NULL
relative	NULL
to	NULL
the	NULL
unstimulated	NULL
cells	NULL
)	NULL
in	NULL
the	NULL
level	NULL
of	NULL
IL-8	NULL
mRNA	NULL
at	NULL
both	NULL
1	NULL
h	NULL
and	NULL
3	NULL
h	NULL
(	NULL
Figures	NULL
4A	NULL
and	NULL
4B	NULL
)	NULL
.	NULL

MBP	NULL
also	NULL
stimulated	NULL
increases	NULL
in	NULL
mRNA	NULL
for	NULL
MIP-1	NULL
«	NULL
and	NULL
(	NULL
5-fold	NULL
and	NULL
3-fold	NULL
,	NULL
respectively	NULL
)	NULL
at	NULL
1	NULL
h	NULL
;	NULL
however	NULL
,	NULL
the	NULL
increases	NULL
were	NULL
absent	NULL
at	NULL
the	NULL
3-h	NULL
time	NULL
point	NULL
.	NULL

Incubation	NULL
with	NULL
LPS	NULL
stimulated	NULL
increases	NULL
in	NULL
the	NULL
level	NULL
of	NULL
IL-8	NULL
mRNA	NULL
at	NULL
the	NULL
3-h	NULL
time	NULL
point	NULL
and	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
MIP-la	NULL
and	NULL
MIP-1B	NULL
mRNA	NULL
at	NULL
both	NULL
time	NULL
points	NULL
(	NULL
Figures	NULL
4A	NULL
and	NULL
4B	NULL
)	NULL
.	NULL

Of	NULL
note	NULL
was	NULL
that	NULL
prein-cubating	NULL
the	NULL
neutrophils	NULL
with	NULL
5	NULL
pg/ml	NULL
actinomycin	NULL
D	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
before	NULL
addition	NULL
of	NULL
the	NULL
stimuli	NULL
blocked	NULL
all	NULL
the	NULL
observed	NULL
increases	NULL
in	NULL
IL-8	NULL
mRNA	NULL
,	NULL
as	NULL
well	NULL
as	NULL
in	NULL
MIP-la	NULL
and	NULL
MIP-1B	NULL
mRNA	NULL
(	NULL
Figure	NULL
4A	NULL
)	NULL
.	NULL

Preincubation	NULL
with	NULL
5	NULL
pg/ml	NULL
actinomycin	NULL
D	NULL
also	NULL
blocked	NULL
MBP-stimulated	NULL
release	NULL
of	NULL
IL-8	NULL
protein	NULL
(	NULL
n	NULL
=	NULL
3	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Absence	NULL
of	NULL
MBP-Stimulated	NULL
MIP-1	NULL
«	NULL
and	NULL
MIP-1f6	NULL
Production	NULL
With	NULL
MBP	NULL
stimulating	NULL
transient	NULL
increases	NULL
in	NULL
MIP-l	NULL
«	NULL
and	NULL
MIP-1B	NULL
mRNA	NULL
(	NULL
Figure	NULL
4A	NULL
)	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
MBP	NULL
to	NULL
stimulate	NULL
release	NULL
of	NULL
MIP-la	NULL
«	NULL
or	NULL
protein	NULL
was	NULL
evaluated	NULL
.	NULL

Results	NULL
obtained	NULL
in	NULL
two	NULL
separate	NULL
experiments	NULL
showed	NULL
that	NULL
incubating	NULL
neutrophils	NULL
with	NULL
2	NULL
MBP	NULL
for	NULL
18	NULL
h	NULL
at	NULL
37°C	NULL
stimulated	NULL
the	NULL
release	NULL
of	NULL
up	NULL
to	NULL
3,400	NULL
pg/ml	NULL
IL-8	NULL
,	NULL
but	NULL
caused	NULL
234	NULL
AMERICAN	NULL
JOURNAL	NULL
OF	NULL
RESPIRATORY	NULL
CELL	NULL
AND	NULL
MOLECULAR	NULL
BIOLOGY	NULL
VOL	NULL
.	NULL

21	NULL
1999	NULL
TABLE	NULL
1	NULL
Stimulation	NULL
of	NULL
MIP-1a	NULL
,	NULL
MIP-1	NULL
(	NULL
B	NULL
,	NULL
and	NULL
IL	NULL
-8	NULL
release	NULL
by	NULL
MBP	NULL
or	NULL
LPS	NULL
MIP-la	NULL
MIP-1B	NULL
IL-8	NULL
Experiment	NULL
Stimulus	NULL
(	NULL
pg/ml	NULL
(	NULL
pg/ml	NULL
(	NULL
pg/ml	NULL
1	NULL
Spont	NULL
<	NULL
31.2	NULL
55	NULL
33	NULL
MBP	NULL
<	NULL
31.2	NULL
150	NULL
3,408	NULL
LPS	NULL
710	NULL
2,360	NULL
1,432	NULL
2	NULL
Spont	NULL
<	NULL
31.2	NULL
37	NULL
<	NULL
15.6	NULL
MBP	NULL
<	NULL
31.2	NULL
84	NULL
1,893	NULL
LPS	NULL
644	NULL
2,130	NULL
1,409	NULL
Definition	NULL
of	NULL
abbreviations	NULL
:	NULL
IL-8	NULL
=	NULL
interleukin	NULL
8	NULL
;	NULL
LPS	NULL
=	NULL
lipopolysaccharide	NULL
;	NULL
MBP	NULL
=	NULL
major	NULL
basic	NULL
protein	NULL
;	NULL
MIP-la	NULL
=	NULL
macrophage	NULL
inhibitory	NULL
protein-la	NULL
;	NULL
MIP-18	NULL
=	NULL
macrophage	NULL
inhibitory	NULL
protein-1B	NULL
.	NULL

Neutrophils	NULL
(	NULL
2	NULL
X	NULL
10	NULL
%	NULL
/ml	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
2	NULL
uM	NULL
MBP	NULL
or	NULL
100	NULL
ng/ml	NULL
LPS	NULL
for	NULL
18	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

Each	NULL
experiment	NULL
used	NULL
cells	NULL
from	NULL
a	NULL
different	NULL
donor	NULL
.	NULL

no	NULL
release	NULL
of	NULL
MIP-la	NULL
and	NULL
negligible	NULL
release	NULL
of	NULL
MIP-1B	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

In	NULL
the	NULL
same	NULL
experiments	NULL
,	NULL
100	NULL
ng/ml	NULL
LPS	NULL
stimulated	NULL
the	NULL
release	NULL
of	NULL
up	NULL
to	NULL
approximately	NULL
1,400	NULL
pg/ml	NULL
IL-8	NULL
,	NULL
700	NULL
pg/ml	NULL
MIP-1	NULL
«	NULL
,	NULL
and	NULL
2,400	NULL
pg/ml	NULL
MIP-1fB	NULL
.	NULL

Effect	NULL
of	NULL
MBP	NULL
Stimulation	NULL
on	NULL
the	NULL
Binding	NULL
Activities	NULL
of	NULL
NF-B	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
NF-IL-6	NULL
The	NULL
finding	NULL
(	NULL
Figure	NULL
4A	NULL
)	NULL
that	NULL
actinomycin	NULL
D	NULL
blocked	NULL
the	NULL
MBP	NULL
-stimulated	NULL
increase	NULL
in	NULL
IL-8	NULL
mRNA	NULL
indicated	NULL
the	NULL
involvement	NULL
of	NULL
a	NULL
transcriptional	NULL
event	NULL
in	NULL
MBP	NULL
-induced	NULL
IL-8	NULL
release	NULL
.	NULL

With	NULL
activation	NULL
of	NULL
NF-KB	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
AP-1	NULL
or	NULL
NF-IL-6	NULL
responsible	NULL
for	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
IL-8	NULL
synthesis	NULL
in	NULL
many	NULL
cells	NULL
(	NULL
29-31	NULL
)	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
MBP	NULL
to	NULL
activate	NULL
NF-KB	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
NF-IL-6	NULL
was	NULL
evaluated	NULL
in	NULL
an	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
5	NULL
,	NULL
incubating	NULL
neutrophils	NULL
with	NULL
5	NULL
wM	NULL
MBP	NULL
for	NULL
20	NULL
or	NULL
60	NULL
min	NULL
at	NULL
37°C	NULL
did	NULL
not	NULL
stimulate	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
binding	NULL
activities	NULL
of	NULL
NF-KB	NULL
or	NULL
AP-1	NULL
.	NULL

In	NULL
the	NULL
same	NULL
experiments	NULL
,	NULL
20	NULL
min	NULL
60	NULL
min	NULL
0	NULL
*	NULL
im	NULL
me	NULL
8	NULL
8	NULL
l	NULL
C	NULL
8	NULL
C	NULL
8	NULL
&	NULL
a	NULL
0	NULL
a	NULL
9	NULL
w	NULL
Z	NULL
m	NULL
Z	NULL
«	NULL
-	NULL
+o+	NULL
a	NULL
+o	NULL
+	NULL
[	NULL
=	NULL
5	NULL
L	NULL
Z2	NULL
v	NULL
o	NULL
a	NULL
a	NULL
&	NULL
ZI	NULL
wo	NULL
a	NULL
a	NULL
a.	NULL
o	NULL
o.	NULL
o	NULL
a.	NULL
a	NULL
©	NULL
o	NULL
a	NULL
a	NULL
a	NULL
.	NULL

®	NULL
3	NULL
w	NULL
u	NULL
4	NULL
4	NULL
#	NULL
3	NULL
w	NULL
u	NULL
4	NULL
4	NULL
H	NULL
+	NULL
-	NULL
<	NULL
NF-kB	NULL
IM	NULL
ad	NULL
-4Ar	NULL
:	NULL
Figure	NULL
5	NULL
.	NULL

Effect	NULL
of	NULL
MBP	NULL
and	NULL
LPS	NULL
stimulation	NULL
on	NULL
binding	NULL
activities	NULL
of	NULL
NF-KB	NULL
and	NULL
AP-1	NULL
.	NULL

Neutrophils	NULL
(	NULL
10	NULL
'	NULL
cells/ml	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
5	NULL
uM	NULL
MBP	NULL
,	NULL
5	NULL
M	NULL
EDN	NULL
,	NULL
1	NULL
pg/ml	NULL
LPS	NULL
,	NULL
or	NULL
in	NULL
RPMI	NULL
buffer	NULL
alone	NULL
for	NULL
20	NULL
or	NULL
60	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
binding	NULL
activities	NULL
were	NULL
determined	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
as	NULL
described	NULL
in	NULL
MarERIALs	NULL
anp	NULL
MetHons	NULL
.	NULL

A	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
probe	NULL
(	NULL
Specific	NULL
)	NULL
or	NULL
unlabeled	NULL
nonspecific	NULL
probe	NULL
(	NULL
AP-2	NULL
for	NULL
NF-KB	NULL
and	NULL
Oct-1	NULL
for	NULL
AP-1	NULL
)	NULL
were	NULL
included	NULL
in	NULL
the	NULL
assay	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
results	NULL
of	NULL
a	NULL
single	NULL
experiment	NULL
that	NULL
is	NULL
representative	NULL
of	NULL
two	NULL
additional	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

1	NULL
g/ml	NULL
LPS	NULL
produced	NULL
an	NULL
increase	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
after	NULL
20	NULL
min	NULL
of	NULL
incubation	NULL
,	NULL
and	NULL
increases	NULL
in	NULL
the	NULL
binding	NULL
activities	NULL
of	NULL
NF-kB	NULL
and	NULL
AP-1	NULL
after	NULL
60	NULL
min	NULL
.	NULL

A	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
specific	NULL
unlabeled	NULL
oligonucleotide	NULL
blocked	NULL
detectable	NULL
binding	NULL
activity	NULL
of	NULL
both	NULL
NF-kB	NULL
and	NULL
AP-1	NULL
(	NULL
Figure	NULL
5	NULL
)	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
was	NULL
also	NULL
partly	NULL
inhibited	NULL
by	NULL
an	NULL
unlabeled	NULL
irrelevant	NULL
oligonucleotide	NULL
(	NULL
AP-2	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
a	NULL
portion	NULL
of	NULL
the	NULL
observed	NULL
binding	NULL
activity	NULL
was	NULL
nonspecific	NULL
.	NULL

No	NULL
NF-IL-6	NULL
binding	NULL
activity	NULL
was	NULL
detected	NULL
in	NULL
any	NULL
of	NULL
the	NULL
experiments	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Effect	NULL
of	NULL
MBP	NULL
on	NULL
the	NULL
Stability	NULL
of	NULL
IL-8	NULL
,	NULL
MIP-1	NULL
«	NULL
,	NULL
and	NULL
MIP-16B	NULL
mRNA	NULL
In	NULL
the	NULL
absence	NULL
of	NULL
an	NULL
MBP	NULL
effect	NULL
on	NULL
the	NULL
binding	NULL
activity	NULL
of	NULL
NF-kB	NULL
or	NULL
AP-1	NULL
,	NULL
the	NULL
possibility	NULL
that	NULL
MBP	NULL
might	NULL
act	NULL
post	NULL
he	NULL
+	NULL
a	NULL
§§i	NULL
\U	NULL
¥	NULL
|	NULL
o	NULL
ON	NULL
IL-8	NULL
mRNA	NULL
{	NULL
%	NULL
)	NULL
a	NULL
&	NULL
I	NULL
40	NULL
|-	NULL
o	NULL
an	NULL
|-20	NULL
|-10	NULL
}	NULL
-o	NULL
a	NULL
1	NULL
2	NULL
a	NULL
4	NULL
a	NULL
Spont	NULL
a	NULL
MBP	NULL
%	NULL
¥	NULL
LPS	NULL
«	NULL
&	NULL
E	NULL
d.	NULL
L	NULL
=	NULL
%	NULL
4	NULL
Z	NULL
<	NULL
\v	NULL
Z	NULL
IC	NULL
4	NULL
\	NULL
\	NULL
in	NULL
G	NULL
d	NULL
¥	NULL
s	NULL
\	NULL
20	NULL
[	NULL
-	NULL
°\\-	NULL
.	NULL

td	NULL
a	NULL
°	NULL
a	NULL
.	NULL

(	NULL
1	NULL
2	NULL
a	NULL
a	NULL
Time	NULL
thr	NULL
}	NULL
Figure	NULL
6	NULL
.	NULL

Effect	NULL
of	NULL
MBP	NULL
and	NULL
LPS	NULL
stimulation	NULL
on	NULL
the	NULL
stability	NULL
of	NULL
IL-8	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
,	NULL
MIP-la	NULL
«	NULL
(	NULL
middle	NULL
panel	NULL
)	NULL
,	NULL
and	NULL
MIP-1B	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
mRNA	NULL
.	NULL

Neutrophils	NULL
(	NULL
10	NULL
``	NULL
/ml	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
5	NULL
uM	NULL
MBP	NULL
,	NULL
1	NULL
g/ml	NULL
LPS	NULL
,	NULL
or	NULL
in	NULL
RPMI	NULL
alone	NULL
for	NULL
2	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

Actinomycin	NULL
D	NULL
(	NULL
5	NULL
g/m	NULL
!	NULL
)	NULL

was	NULL
added	NULL
(	NULL
time	NULL
zero	NULL
)	NULL
,	NULL
and	NULL
total	NULL
RNA	NULL
was	NULL
isolated	NULL
at	NULL
time	NULL
zero	NULL
and	NULL
after	NULL
an	NULL
additional	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
4	NULL
h	NULL
of	NULL
incubation	NULL
at	NULL
37°C	NULL
.	NULL

Expression	NULL
of	NULL
IL-8	NULL
,	NULL
MIP-1	NULL
«	NULL
,	NULL
and	NULL
MIP-1B	NULL
mRNA	NULL
was	NULL
assessed	NULL
with	NULL
an	NULL
RNase	NULL
protection	NULL
assay	NULL
.	NULL

Levels	NULL
of	NULL
IL-8	NULL
,	NULL
MIP-1a	NULL
,	NULL
and	NULL
MIP-1B	NULL
mRNA	NULL
were	NULL
normalized	NULL
to	NULL
that	NULL
of	NULL
GAPDH	NULL
mRNA	NULL
,	NULL
and	NULL
the	NULL
average	NULL
of	NULL
two	NULL
experiments	NULL
is	NULL
presented	NULL
as	NULL
the	NULL
percent	NULL
of	NULL
mRNA	NULL
at	NULL
time	NULL
zero	NULL
.	NULL

Page	NULL
,	NULL
Gleich	NULL
,	NULL
Roebuck	NULL
,	NULL
et	NULL
al	NULL
.	NULL

:	NULL
Stimulation	NULL
of	NULL
Neutrophil	NULL
IL-8	NULL
Production	NULL
235	NULL
transcriptionally	NULL
to	NULL
stabilize	NULL
IL-8	NULL
mRNA	NULL
was	NULL
evaluated	NULL
.	NULL

Neutrophils	NULL
were	NULL
incubated	NULL
with	NULL
5	NULL
M	NULL
MBP	NULL
or	NULL
1	NULL
pg/ml	NULL
LPS	NULL
for	NULL
2	NULL
h	NULL
at	NULL
37°C	NULL
,	NULL
and	NULL
5	NULL
ug/ml	NULL
actinomycin	NULL
D	NULL
was	NULL
then	NULL
added	NULL
(	NULL
time	NULL
zero	NULL
)	NULL
.	NULL

The	NULL
level	NULL
of	NULL
IL-8	NULL
mRNA	NULL
and	NULL
,	NULL
for	NULL
com-parison	NULL
,	NULL
the	NULL
levels	NULL
of	NULL
MIP-1a	NULL
«	NULL
and	NULL
MIP-1B	NULL
mRNA	NULL
,	NULL
were	NULL
measured	NULL
with	NULL
the	NULL
RNase	NULL
protection	NULL
assay	NULL
at	NULL
time	NULL
zero	NULL
and	NULL
after	NULL
an	NULL
additional	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
4	NULL
h	NULL
of	NULL
incubation	NULL
at	NULL
37°C	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
actinomycin	NULL
D.	NULL
The	NULL
results	NULL
show	NULL
that	NULL
more	NULL
than	NULL
80	NULL
%	NULL
of	NULL
the	NULL
IL-8	NULL
mRNA	NULL
in	NULL
the	NULL
MBP-stimulated	NULL
neutrophils	NULL
was	NULL
still	NULL
present	NULL
after	NULL
4	NULL
h	NULL
of	NULL
incubation	NULL
with	NULL
the	NULL
actinomycin	NULL
D	NULL
,	NULL
whereas	NULL
50	NULL
%	NULL
of	NULL
the	NULL
IL-8	NULL
mRNA	NULL
in	NULL
unstimulated	NULL
neutrophils	NULL
was	NULL
degraded	NULL
by	NULL
approximately	NULL
2.5	NULL
h	NULL
(	NULL
Figure	NULL
6	NULL
)	NULL
.	NULL

Incubation	NULL
with	NULL
MBP	NULL
also	NULL
increased	NULL
the	NULL
stability	NULL
of	NULL
MIP-1B	NULL
mRNA	NULL
(	NULL
T	NULL
;	NULL
,	NULL
~	NULL
2	NULL
h	NULL
in	NULL
MBP	NULL
-stimulated	NULL
cells	NULL
,	NULL
versus	NULL
T	NULL
;	NULL
,	NULL
<	NULL
1	NULL
h	NULL
in	NULL
unstimulated	NULL
cells	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
incubation	NULL
with	NULL
LPS	NULL
enhanced	NULL
the	NULL
mRNA	NULL
stability	NULL
of	NULL
all	NULL
three	NULL
chemokines	NULL
(	NULL
Figure	NULL
6	NULL
)	NULL
.	NULL

Discussion	NULL
These	NULL
results	NULL
described	NULL
show	NULL
that	NULL
MBP	NULL
is	NULL
an	NULL
effective	NULL
stimulus	NULL
for	NULL
IL-8	NULL
production	NULL
by	NULL
neutrophils	NULL
.	NULL

As	NULL
such	NULL
,	NULL
MBP	NULL
joins	NULL
a	NULL
prominent	NULL
list	NULL
of	NULL
inflammatory	NULL
reactants	NULL
known	NULL
to	NULL
stimulate	NULL
IL-8	NULL
release	NULL
by	NULL
neutrophils	NULL
(	NULL
14-18	NULL
,	NULL
32	NULL
)	NULL
.	NULL

The	NULL
level	NULL
of	NULL
IL-8	NULL
production	NULL
stimulated	NULL
by	NULL
MBP	NULL
is	NULL
comparable	NULL
to	NULL
that	NULL
stimulated	NULL
by	NULL
optimal	NULL
concentrations	NULL
of	NULL
LPS	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
-a	NULL
«	NULL
,	NULL
IL-1	NULL
$	NULL
B	NULL
,	NULL
and	NULL
formylmethionyl	NULL
leucyl	NULL
phenylalanine	NULL
(	NULL
14-18	NULL
)	NULL
,	NULL
indicating	NULL
a	NULL
similar	NULL
efficacy	NULL
for	NULL
MBP	NULL
and	NULL
these	NULL
stimuli	NULL
.	NULL

MBP	NULL
,	NULL
however	NULL
,	NULL
is	NULL
less	NULL
potent	NULL
than	NULL
many	NULL
of	NULL
the	NULL
other	NULL
inflammatory	NULL
reactants	NULL
,	NULL
with	NULL
MBP	NULL
stimulating	NULL
IL-8	NULL
release	NULL
at	NULL
concentrations	NULL
above	NULL
1	NULL
M.	NULL
A	NULL
Ithough	NULL
the	NULL
concentrations	NULL
of	NULL
MBP	NULL
achieved	NULL
locally	NULL
within	NULL
tissues	NULL
can	NULL
not	NULL
be	NULL
quantified	NULL
,	NULL
MBP	NULL
levels	NULL
of	NULL
up	NULL
to	NULL
approximately	NULL
90	NULL
ug/ml	NULL
have	NULL
been	NULL
measured	NULL
in	NULL
the	NULL
sputum	NULL
of	NULL
symptomatic	NULL
asthma	NULL
patients	NULL
(	NULL
33	NULL
)	NULL
.	NULL

These	NULL
values	NULL
,	NULL
together	NULL
with	NULL
an	NULL
MBP	NULL
content	NULL
of	NULL
approximately	NULL
9	NULL
jwg/10®	NULL
eosinophils	NULL
(	NULL
34	NULL
)	NULL
,	NULL
suggest	NULL
that	NULL
the	NULL
2	NULL
M	NULL
concentration	NULL
of	NULL
MBP	NULL
,	NULL
which	NULL
was	NULL
consistently	NULL
found	NULL
to	NULL
be	NULL
effective	NULL
in	NULL
the	NULL
present	NULL
study	NULL
,	NULL
can	NULL
at	NULL
least	NULL
be	NULL
approached	NULL
within	NULL
the	NULL
tissues	NULL
.	NULL

The	NULL
results	NULL
presented	NULL
here	NULL
clearly	NULL
exclude	NULL
any	NULL
possible	NULL
LPS	NULL
contamination	NULL
as	NULL
a	NULL
basis	NULL
for	NULL
the	NULL
MBP	NULL
activity	NULL
.	NULL

Indeed	NULL
,	NULL
whereas	NULL
LPS	NULL
stimulates	NULL
a	NULL
prolonged	NULL
(	NULL
at	NULL
least	NULL
20	NULL
h	NULL
)	NULL
release	NULL
of	NULL
IL-8	NULL
by	NULL
neutrophils	NULL
(	NULL
14	NULL
,	NULL
16	NULL
)	NULL
,	NULL
release	NULL
of	NULL
IL-8	NULL
stimulated	NULL
by	NULL
MBP	NULL
tended	NULL
to	NULL
reach	NULL
a	NULL
plateau	NULL
with	NULL
respect	NULL
to	NULL
time	NULL
after	NULL
approximately	NULL
10	NULL
h	NULL
of	NULL
incubation	NULL
.	NULL

Given	NULL
this	NULL
,	NULL
the	NULL
time	NULL
course	NULL
for	NULL
MBP-stimulated	NULL
IL-8	NULL
release	NULL
is	NULL
similar	NULL
to	NULL
the	NULL
time	NULL
course	NULL
for	NULL
IL-8	NULL
release	NULL
stimulated	NULL
by	NULL
TNF-a	NULL
or	NULL
IL-1	NULL
$	NULL
B	NULL
(	NULL
14	NULL
)	NULL
.	NULL

These	NULL
results	NULL
also	NULL
show	NULL
that	NULL
among	NULL
the	NULL
basic	NULL
proteins	NULL
present	NULL
in	NULL
eosinophil	NULL
granules	NULL
,	NULL
MBP	NULL
is	NULL
unique	NULL
in	NULL
its	NULL
ability	NULL
to	NULL
stimulate	NULL
neutrophil	NULL
IL-8	NULL
production	NULL
,	NULL
at	NULL
least	NULL
at	NULL
a	NULL
concentration	NULL
consistently	NULL
effective	NULL
for	NULL
MBP	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
the	NULL
present	NULL
findings	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
earlier	NULL
observations	NULL
that	NULL
ECP	NULL
,	NULL
EDN	NULL
,	NULL
and	NULL
EPO	NULL
do	NULL
not	NULL
share	NULL
the	NULL
ability	NULL
of	NULL
MBP	NULL
to	NULL
stimulate	NULL
neutrophil	NULL
superoxide	NULL
anion	NULL
production	NULL
at	NULL
a	NULL
concentration	NULL
optimal	NULL
for	NULL
MBP	NULL
(	NULL
2	NULL
;	NULL
S.	NULL
Page	NULL
and	NULL
L.	NULL
Thomas	NULL
,	NULL
unpublished	NULL
observation	NULL
)	NULL
.	NULL

A	NULL
Ithough	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
higher	NULL
concentrations	NULL
of	NULL
ECP	NULL
,	NULL
EDN	NULL
,	NULL
or	NULL
EPO	NULL
may	NULL
stimulate	NULL
IL-8	NULL
release	NULL
by	NULL
neutrophils	NULL
,	NULL
such	NULL
concentrations	NULL
would	NULL
begin	NULL
to	NULL
exceed	NULL
concentrations	NULL
plausibly	NULL
expected	NULL
to	NULL
be	NULL
achieved	NULL
clinically	NULL
.	NULL

Further	NULL
,	NULL
it	NULL
is	NULL
worth	NULL
noting	NULL
that	NULL
when	NULL
expressed	NULL
in	NULL
g/ml	NULL
protein	NULL
,	NULL
the	NULL
2	NULL
M	NULL
concentrations	NULL
of	NULL
the	NULL
21-kD	NULL
ECP	NULL
and	NULL
66-kD	NULL
EPO	NULL
(	NULL
1	NULL
)	NULL
are	NULL
50	NULL
%	NULL
and	NULL
almost	NULL
5S-fold	NULL
greater	NULL
,	NULL
respectively	NULL
,	NULL
than	NULL
that	NULL
of	NULL
the	NULL
same	NULL
concentration	NULL
of	NULL
13.9-kD	NULL
MBP	NULL
.	NULL

EPO	NULL
also	NULL
did	NULL
not	NULL
stimulate	NULL
significant	NULL
levels	NULL
of	NULL
IL-8	NULL
production	NULL
at	NULL
the	NULL
concentrations	NULL
(	NULL
0.1-0.3	NULL
wM	NULL
)	NULL
previously	NULL
reported	NULL
to	NULL
stimulate	NULL
neutrophil	NULL
aggregation	NULL
and	NULL
adherence	NULL
(	NULL
27	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
although	NULL
the	NULL
enzymatic	NULL
activity	NULL
of	NULL
EPO	NULL
is	NULL
responsible	NULL
for	NULL
some	NULL
EPO	NULL
actions	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
,	NULL
EPO	NULL
did	NULL
not	NULL
stimulate	NULL
IL-8	NULL
release	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
its	NULL
substrate	NULL
,	NULL
H,0	NULL
;	NULL
.	NULL

This	NULL
finding	NULL
may	NULL
partly	NULL
reflect	NULL
the	NULL
use	NULL
of	NULL
chloride	NULL
,	NULL
which	NULL
is	NULL
less	NULL
optimal	NULL
than	NULL
iodide	NULL
or	NULL
bromide	NULL
(	NULL
35	NULL
,	NULL
37	NULL
)	NULL
,	NULL
as	NULL
a	NULL
halide	NULL
for	NULL
EPO	NULL
enzymatic	NULL
activity	NULL
,	NULL
but	NULL
it	NULL
has	NULL
also	NULL
been	NULL
reported	NULL
that	NULL
the	NULL
enzymatic	NULL
activity	NULL
of	NULL
EPO	NULL
is	NULL
inhibited	NULL
after	NULL
binding	NULL
of	NULL
EPO	NULL
to	NULL
neutrophils	NULL
(	NULL
27	NULL
)	NULL
.	NULL

A	NULL
striking	NULL
feature	NULL
of	NULL
the	NULL
MBP	NULL
molecule	NULL
is	NULL
its	NULL
strongly	NULL
basic	NULL
charge	NULL
(	NULL
1	NULL
)	NULL
,	NULL
and	NULL
,	NULL
indeed	NULL
,	NULL
many	NULL
of	NULL
the	NULL
activities	NULL
described	NULL
for	NULL
MBP	NULL
have	NULL
been	NULL
attributed	NULL
to	NULL
its	NULL
charge	NULL
.	NULL

The	NULL
failure	NULL
,	NULL
however	NULL
,	NULL
of	NULL
both	NULL
ECP	NULL
,	NULL
which	NULL
has	NULL
a	NULL
charge	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
MBP	NULL
(	NULL
pI	NULL
values	NULL
of	NULL
10.8	NULL
and	NULL
10.9	NULL
,	NULL
respectively	NULL
)	NULL
and	NULL
a	NULL
similar	NULL
arginine	NULL
content	NULL
(	NULL
14	NULL
%	NULL
each	NULL
)	NULL
,	NULL
and	NULL
of	NULL
EPO	NULL
,	NULL
which	NULL
is	NULL
likewise	NULL
strongly	NULL
basic	NULL
(	NULL
pI	NULL
of	NULL
10.8	NULL
)	NULL
(	NULL
1	NULL
)	NULL
,	NULL
to	NULL
stimulate	NULL
neutrophil	NULL
IL-8	NULL
release	NULL
suggests	NULL
that	NULL
the	NULL
basic	NULL
charge	NULL
alone	NULL
does	NULL
not	NULL
account	NULL
for	NULL
the	NULL
activity	NULL
of	NULL
MBP	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
conclusion	NULL
,	NULL
it	NULL
has	NULL
been	NULL
found	NULL
that	NULL
protamine	NULL
,	NULL
a	NULL
4.8-kD	NULL
polypeptide	NULL
of	NULL
which	NULL
66	NULL
%	NULL
consists	NULL
of	NULL
arginine	NULL
(	NULL
28	NULL
)	NULL
,	NULL
and	NULL
a	NULL
14-kD	NULL
polymer	NULL
of	NULL
L-arginine	NULL
(	NULL
Poly-R	NULL
)	NULL
,	NULL
at	NULL
a	NULL
concentration	NULL
equivalent	NULL
to	NULL
the	NULL
arginine	NULL
content	NULL
of	NULL
MBP	NULL
,	NULL
also	NULL
do	NULL
not	NULL
stimulate	NULL
IL-8	NULL
release	NULL
.	NULL

Interestingly	NULL
,	NULL
it	NULL
has	NULL
recently	NULL
been	NULL
reported	NULL
that	NULL
MBP	NULL
also	NULL
stimulates	NULL
TNF-a	NULL
production	NULL
by	NULL
murine	NULL
bone	NULL
marrow-derived	NULL
mast	NULL
cells	NULL
after	NULL
priming	NULL
by	NULL
stem-cell	NULL
factor	NULL
(	NULL
38	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
poly-L-arginine	NULL
was	NULL
found	NULL
to	NULL
stimulate	NULL
TNF-	NULL
«	NULL
release	NULL
independently	NULL
of	NULL
priming	NULL
by	NULL
stem-cell	NULL
factor	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Earlier	NULL
results	NULL
demonstrated	NULL
the	NULL
capacity	NULL
of	NULL
MBP	NULL
to	NULL
stimulate	NULL
IL-8	NULL
production	NULL
by	NULL
eosinophils	NULL
via	NULL
a	NULL
transcrip-tion-dependent	NULL
mechanism	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
inhibition	NULL
of	NULL
MBP	NULL
-induced	NULL
increases	NULL
in	NULL
IL-8	NULL
mRNA	NULL
by	NULL
actinomycin	NULL
D	NULL
(	NULL
19	NULL
)	NULL
.	NULL

The	NULL
results	NULL
presented	NULL
here	NULL
indicate	NULL
that	NULL
MBP	NULL
-stimulated	NULL
IL-8	NULL
release	NULL
by	NULL
neutrophils	NULL
is	NULL
likewise	NULL
the	NULL
result	NULL
of	NULL
new	NULL
protein	NULL
synthesis	NULL
,	NULL
since	NULL
actinomycin	NULL
D	NULL
blocked	NULL
the	NULL
MBP	NULL
-stimulated	NULL
increases	NULL
in	NULL
both	NULL
IL-8	NULL
mRNA	NULL
synthesis	NULL
and	NULL
IL-8	NULL
protein	NULL
release	NULL
.	NULL

MBP	NULL
-induced	NULL
IL-8	NULL
synthesis	NULL
ap-pears	NULL
,	NULL
however	NULL
,	NULL
to	NULL
occur	NULL
independently	NULL
of	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
binding	NULL
activity	NULL
of	NULL
NF-kB	NULL
,	NULL
which	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
AP-1	NULL
or	NULL
NF-IL-6	NULL
regulates	NULL
IL-8	NULL
gene	NULL
transcription	NULL
in	NULL
many	NULL
cell	NULL
types	NULL
(	NULL
29-31	NULL
)	NULL
.	NULL

MBP	NULL
stimulation	NULL
was	NULL
likewise	NULL
not	NULL
accompanied	NULL
by	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
binding	NULL
activity	NULL
of	NULL
AP-1	NULL
,	NULL
and	NULL
no	NULL
NF-IL-6	NULL
binding	NULL
activity	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
neutrophil	NULL
extracts	NULL
in	NULL
our	NULL
experiments	NULL
.	NULL

In	NULL
accordance	NULL
with	NULL
previous	NULL
reports	NULL
(	NULL
26	NULL
,	NULL
39	NULL
)	NULL
,	NULL
LPS-induced	NULL
activation	NULL
was	NULL
accompanied	NULL
by	NULL
increases	NULL
in	NULL
the	NULL
binding	NULL
activities	NULL
of	NULL
both	NULL
NF-kB	NULL
and	NULL
AP-1	NULL
,	NULL
although	NULL
a	NULL
portion	NULL
of	NULL
the	NULL
observed	NULL
increase	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
was	NULL
nonspecific	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T-cells	NULL
(	NULL
NF-AT	NULL
)	NULL
by	NULL
a	NULL
sustained	NULL
increase	NULL
in	NULL
the	NULL
cytosolic	NULL
free	NULL
calcium	NULL
concentration	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
regulation	NULL
of	NULL
IL-8	NULL
synthesis	NULL
in	NULL
neutrophils	NULL
(	NULL
40	NULL
)	NULL
.	NULL

MBP	NULL
,	NULL
however	NULL
,	NULL
stimulates	NULL
an	NULL
increase	NULL
in	NULL
cytosolic	NULL
free	NULL
calcium	NULL
concentration	NULL
only	NULL
in	NULL
cytochalasin	NULL
B-treated	NULL
neutrophils	NULL
(	NULL
23	NULL
)	NULL
,	NULL
which	NULL
were	NULL
not	NULL
used	NULL
in	NULL
the	NULL
present	NULL
study	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
MBP	NULL
-induced	NULL
IL-8	NULL
synthesis	NULL
in	NULL
neutrophils	NULL
re	NULL
236	NULL
AMERICAN	NULL
JOURNAL	NULL
OF	NULL
RESPIRATORY	NULL
CELL	NULL
AND	NULL
MOLECULAR	NULL
BIOLOGY	NULL
VOL	NULL
.	NULL

21	NULL
1999	NULL
quires	NULL
a	NULL
novel	NULL
transcription	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
,	NULL
or	NULL
is	NULL
due	NULL
to	NULL
the	NULL
inhibition	NULL
or	NULL
removal	NULL
of	NULL
a	NULL
repressor	NULL
protein	NULL
such	NULL
as	NULL
Oct-1	NULL
,	NULL
which	NULL
negatively	NULL
regulates	NULL
IL-8	NULL
synthesis	NULL
(	NULL
41	NULL
)	NULL
,	NULL
can	NULL
not	NULL
be	NULL
excluded	NULL
.	NULL

The	NULL
present	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
regulation	NULL
of	NULL
MBP	NULL
-stimulated	NULL
IL-8	NULL
production	NULL
in	NULL
neutrophils	NULL
may	NULL
also	NULL
occur	NULL
posttranscriptionally	NULL
through	NULL
stabilization	NULL
of	NULL
IL-8	NULL
mRNA	NULL
,	NULL
as	NULL
observed	NULL
in	NULL
other	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
various	NULL
stimuli	NULL
(	NULL
42-45	NULL
)	NULL
.	NULL

The	NULL
3	NULL
'	NULL
untranslated	NULL
region	NULL
of	NULL
IL-8	NULL
mRNA	NULL
contains	NULL
tandem	NULL
repeats	NULL
of	NULL
adenine/uracil	NULL
(	NULL
A	NULL
U	NULL
)	NULL
-rich	NULL
regions	NULL
that	NULL
are	NULL
often	NULL
associated	NULL
with	NULL
unstable	NULL
mRNA	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Specific	NULL
AU-binding	NULL
proteins	NULL
have	NULL
been	NULL
identified	NULL
(	NULL
47	NULL
,	NULL
48	NULL
)	NULL
,	NULL
and	NULL
the	NULL
finding	NULL
that	NULL
cycloheximide	NULL
induces	NULL
large	NULL
increases	NULL
in	NULL
IL-8	NULL
mRNA	NULL
(	NULL
43	NULL
,	NULL
49	NULL
)	NULL
has	NULL
implicated	NULL
the	NULL
binding	NULL
of	NULL
specific	NULL
proteins	NULL
to	NULL
AU-rich	NULL
regions	NULL
in	NULL
the	NULL
targeting	NULL
of	NULL
IL-8	NULL
mRNA	NULL
for	NULL
degradation	NULL
.	NULL

Specific	NULL
AU-binding	NULL
proteins	NULL
have	NULL
not	NULL
yet	NULL
been	NULL
identified	NULL
in	NULL
neutrophils	NULL
,	NULL
but	NULL
a	NULL
similar	NULL
mechanism	NULL
probably	NULL
occurs	NULL
in	NULL
neutrophils	NULL
.	NULL

Cycloheximide	NULL
induces	NULL
large	NULL
increases	NULL
in	NULL
neutrophil	NULL
IL-8	NULL
mRNA	NULL
levels	NULL
(	NULL
14	NULL
,	NULL
50	NULL
)	NULL
,	NULL
and	NULL
the	NULL
inhibition	NULL
of	NULL
LPS-stimulated	NULL
IL-8	NULL
production	NULL
by	NULL
IL-10	NULL
(	NULL
51	NULL
,	NULL
52	NULL
)	NULL
is	NULL
correlated	NULL
with	NULL
a	NULL
decreased	NULL
stability	NULL
of	NULL
IL-8	NULL
mRNA	NULL
that	NULL
depends	NULL
on	NULL
protein	NULL
synthesis	NULL
(	NULL
51	NULL
)	NULL
.	NULL

IL-10	NULL
likewise	NULL
inhibits	NULL
LPS-stimulated	NULL
production	NULL
of	NULL
MIP-1a	NULL
«	NULL
and	NULL
MIP-1B	NULL
by	NULL
a	NULL
similar	NULL
mechanism	NULL
(	NULL
51	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
MBP	NULL
also	NULL
stabilized	NULL
MIP-1B	NULL
mRNA	NULL
,	NULL
but	NULL
not	NULL
for	NULL
the	NULL
same	NULL
duration	NULL
as	NULL
IL-8	NULL
mRNA	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
findings	NULL
that	NULL
MBP	NULL
stimulated	NULL
larger	NULL
but	NULL
more	NULL
transient	NULL
increases	NULL
in	NULL
MIP-1	NULL
«	NULL
and	NULL
MIP-1B	NULL
mRNA	NULL
,	NULL
but	NULL
did	NULL
not	NULL
stimulate	NULL
MIP-la	NULL
or	NULL
MIP-1B	NULL
protein	NULL
production	NULL
,	NULL
suggest	NULL
that	NULL
prolonged	NULL
stability	NULL
of	NULL
IL-8	NULL
mRNA	NULL
plays	NULL
a	NULL
major	NULL
role	NULL
in	NULL
the	NULL
action	NULL
of	NULL
MBP	NULL
.	NULL

It	NULL
is	NULL
worth	NULL
noting	NULL
in	NULL
this	NULL
context	NULL
that	NULL
the	NULL
IL-8	NULL
mRNA	NULL
level	NULL
in	NULL
unstimulated	NULL
neutrophils	NULL
was	NULL
increased	NULL
at	NULL
1	NULL
h	NULL
in	NULL
the	NULL
present	NULL
experiments	NULL
.	NULL

Adherence	NULL
to	NULL
plastic	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
increases	NULL
in	NULL
neutrophil	NULL
IL-8	NULL
mRNA	NULL
levels	NULL
(	NULL
14	NULL
)	NULL
,	NULL
and	NULL
the	NULL
possibility	NULL
that	NULL
adherence	NULL
contributes	NULL
to	NULL
the	NULL
increase	NULL
observed	NULL
here	NULL
can	NULL
not	NULL
be	NULL
excluded	NULL
.	NULL

In	NULL
any	NULL
event	NULL
,	NULL
the	NULL
increased	NULL
IL-8	NULL
mRNA	NULL
level	NULL
found	NULL
in	NULL
unstimulated	NULL
neutrophils	NULL
would	NULL
provide	NULL
a	NULL
basis	NULL
for	NULL
the	NULL
posttranscriptional	NULL
effect	NULL
of	NULL
MBP	NULL
.	NULL

Although	NULL
MBP	NULL
was	NULL
first	NULL
recognized	NULL
for	NULL
its	NULL
cytotoxicity	NULL
(	NULL
1	NULL
)	NULL
,	NULL
it	NULL
is	NULL
now	NULL
clear	NULL
that	NULL
this	NULL
protein	NULL
also	NULL
exhibits	NULL
many	NULL
noncytotoxic	NULL
activities	NULL
,	NULL
including	NULL
the	NULL
stimulation	NULL
of	NULL
neutrophil	NULL
IL-8	NULL
production	NULL
.	NULL

Besides	NULL
being	NULL
a	NULL
potent	NULL
chemoattractant	NULL
and	NULL
stimulus	NULL
for	NULL
neutrophils	NULL
(	NULL
8	NULL
,	NULL
10	NULL
)	NULL
,	NULL
IL-8	NULL
is	NULL
also	NULL
a	NULL
chemoattractant	NULL
for	NULL
T-lymphocytes	NULL
(	NULL
53	NULL
)	NULL
and	NULL
for	NULL
IL-5-primed	NULL
eosinophils	NULL
(	NULL
54	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
stimulus	NULL
for	NULL
basophils	NULL
primed	NULL
by	NULL
IL-3	NULL
(	NULL
55	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
recent	NULL
findings	NULL
obtained	NULL
with	NULL
the	NULL
human	NULL
mast	NULL
cell	NULL
line	NULL
HMC-1	NULL
indicate	NULL
that	NULL
IL-8	NULL
may	NULL
also	NULL
be	NULL
chemotatic	NULL
for	NULL
mast	NULL
cells	NULL
(	NULL
56	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
MBP	NULL
-induced	NULL
IL-8	NULL
production	NULL
by	NULL
neutrophils	NULL
could	NULL
contribute	NULL
to	NULL
inflammatory	NULL
events	NULL
characteristic	NULL
of	NULL
chronic	NULL
asthma	NULL
.	NULL

However	NULL
,	NULL
we	NULL
propose	NULL
that	NULL
the	NULL
effect	NULL
of	NULL
MBP	NULL
on	NULL
neutrophil	NULL
IL-8	NULL
release	NULL
may	NULL
be	NULL
even	NULL
more	NULL
relevant	NULL
to	NULL
the	NULL
pathophysiology	NULL
of	NULL
acute	NULL
asthma	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
promoting	NULL
additional	NULL
neutrophil	NULL
influx	NULL
,	NULL
IL-8	NULL
release	NULL
could	NULL
enhance	NULL
or	NULL
prolong	NULL
neutrophil	NULL
activation	NULL
in	NULL
an	NULL
autocrinelike	NULL
manner	NULL
.	NULL

The	NULL
resulting	NULL
increased	NULL
release	NULL
of	NULL
elastase	NULL
and	NULL
other	NULL
neutrophil	NULL
mediators	NULL
(	NULL
57	NULL
)	NULL
could	NULL
exacerbate	NULL
changes	NULL
such	NULL
as	NULL
formation	NULL
of	NULL
the	NULL
mucus	NULL
plugs	NULL
observed	NULL
in	NULL
fatal	NULL
asthma	NULL
(	NULL
7	NULL
)	NULL
.	NULL

An	NULL
association	NULL
between	NULL
eosinophil	NULL
infiltrates	NULL
and	NULL
exacerbations	NULL
in	NULL
chronic	NULL
bronchitis	NULL
(	NULL
58	NULL
)	NULL
suggests	NULL
that	NULL
MBP	NULL
-stimulated	NULL
IL-8	NULL
production	NULL
may	NULL
also	NULL
have	NULL
implications	NULL
for	NULL
other	NULL
inflammatory	NULL
lung	NULL
diseases	NULL
.	NULL

Acknowledgments	NULL
:	NULL
The	NULL
authors	NULL
thank	NULL
James	NULL
Checkel	NULL
and	NULL
David	NULL
Loegering	NULL
for	NULL
isolation	NULL
of	NULL
the	NULL
eosinophil	NULL
proteins	NULL
.	NULL

They	NULL
also	NULL
thank	NULL
Dr.	NULL
Venkatesh	NULL
Lakshmi-narayanan	NULL
for	NULL
assistance	NULL
with	NULL
the	NULL
RNase	NULL
protection	NULL
assays	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
grants	NULL
A132041	NULL
and	NULL
A1O9728	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Kita	NULL
,	NULL
H.	NULL
,	NULL
C.	NULL
R.	NULL
Adolphson	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Gleich	NULL
.	NULL

1998	NULL
.	NULL

Biology	NULL
of	NULL
eosinophils	NULL
.	NULL

In	NULL
Allergy	NULL
.	NULL

Principles	NULL
and	NULL
Practice	NULL
.	NULL

Vol	NULL
.	NULL

1	NULL
.	NULL

E.	NULL
Middleton	NULL
,	NULL
Jr.	NULL
,	NULL
E.	NULL
F.	NULL
Ellis	NULL
,	NULL
J.	NULL
W.	NULL
Yuninger	NULL
,	NULL
C.	NULL
A.	NULL
Reed	NULL
,	NULL
N.	NULL
F.	NULL
Adkinson	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
W.	NULL
W.	NULL
Busse	NULL
,	NULL
editors	NULL
.	NULL

Mosby	NULL
,	NULL
St.	NULL
Louis	NULL
.	NULL

242-260	NULL
.	NULL

2	NULL
.	NULL

Moy	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
G.	NULL
J.	NULL
Gleich	NULL
,	NULL
and	NULL
L.	NULL
L.	NULL
Thomas	NULL
.	NULL

1990	NULL
.	NULL

Noncytotoxic	NULL
activation	NULL
neutrophils	NULL
by	NULL
eosinophil	NULL
granule	NULL
major	NULL
basic	NULL
protein	NULL
:	NULL
synergistic	NULL
influence	NULL
on	NULL
superoxide	NULL
anion	NULL
generation	NULL
and	NULL
lysosomal	NULL
enzyme	NULL
release	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

145:2626-2632	NULL
.	NULL

3	NULL
.	NULL

Moy	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
L.	NULL
L.	NULL
Thomas	NULL
,	NULL
and	NULL
L.	NULL
C.	NULL
Whisler	NULL
.	NULL

1993	NULL
.	NULL

Eosinophil	NULL
major	NULL
basic	NULL
protein	NULL
enhances	NULL
the	NULL
expression	NULL
of	NULL
neutrophil	NULL
CR	NULL
3	NULL
and	NULL
p150,95	NULL
.	NULL

J	NULL
.	NULL

A	NULL
Hergy	NULL
Clin	NULL
.	NULL

Immunol	NULL
.	NULL

92:598-606	NULL
.	NULL

4	NULL
.	NULL

Fahy	NULL
,	NULL
J.	NULL
V.	NULL
,	NULL
K.	NULL
W.	NULL
Kim	NULL
,	NULL
J.	NULL
Liu	NULL
,	NULL
and	NULL
H.	NULL
A.	NULL
Boushey	NULL
.	NULL

1995	NULL
.	NULL

Prominent	NULL
neutro-philic	NULL
inflammation	NULL
in	NULL
sputum	NULL
from	NULL
subjects	NULL
with	NULL
asthma	NULL
exacerbation	NULL
.	NULL

J	NULL
.	NULL

Allergy	NULL
Clin	NULL
.	NULL

Immunol	NULL
.	NULL

95:843-852.	NULL
.	NULL

Grunberg	NULL
,	NULL
K.	NULL
,	NULL
H.	NULL
H.	NULL
Smits	NULL
,	NULL
M.	NULL
C.	NULL
Timmers	NULL
,	NULL
E.	NULL
P.	NULL
de	NULL
Klerk	NULL
,	NULL
R.	NULL
J.	NULL
Dolhain	NULL
,	NULL
E.	NULL
C.	NULL
Dick	NULL
,	NULL
P.	NULL
S.	NULL
Hiemstra	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Sterk	NULL
.	NULL

1997	NULL
.	NULL

Experimental	NULL
rhinovirus	NULL
16	NULL
infection	NULL
:	NULL
effects	NULL
on	NULL
cell	NULL
differentials	NULL
and	NULL
soluble	NULL
markers	NULL
in	NULL
sputum	NULL
in	NULL
asthmatic	NULL
subjects	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Respir	NULL
.	NULL

Crit	NULL
.	NULL

Care	NULL
Med	NULL
.	NULL

156:609-616	NULL
.	NULL

6	NULL
.	NULL

Lamblin	NULL
,	NULL
C.	NULL
,	NULL
P.	NULL
Gosset	NULL
,	NULL
L.	NULL
Tillie-Leblond	NULL
,	NULL
F.	NULL
Saulnier	NULL
,	NULL
C.	NULL
H.	NULL
Marquette	NULL
,	NULL
B.	NULL
Wallaert	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Tonnel	NULL
.	NULL

1998	NULL
.	NULL

Bronchial	NULL
neutrophilia	NULL
in	NULL
patients	NULL
with	NULL
noninfectious	NULL
status	NULL
asthmaticus	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Respir	NULL
.	NULL

Crit	NULL
.	NULL

Care	NULL
Med	NULL
.	NULL

157:394-402	NULL
.	NULL

7	NULL
.	NULL

Sur	NULL
,	NULL
S.	NULL
,	NULL
T.	NULL
B.	NULL
Crotty	NULL
,	NULL
G.	NULL
M.	NULL
Kephart	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Hyma	NULL
,	NULL
T.	NULL
V.	NULL
Colby	NULL
,	NULL
C.	NULL
E.	NULL
Reed	NULL
,	NULL
L.	NULL
W.	NULL
Hunt	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Gleich	NULL
.	NULL

1993	NULL
.	NULL

Severc-onset	NULL
fatal	NULL
asthma	NULL
:	NULL
a	NULL
distinct	NULL
entity	NULL
with	NULL
few	NULL
cosinophils	NULL
and	NULL
relatively	NULL
more	NULL
neutrophils	NULL
in	NULL
the	NULL
airway	NULL
submucosa	NULL
?	NULL

Am	NULL
.	NULL

Rev	NULL
.	NULL

Respir	NULL
.	NULL

Dis	NULL
.	NULL

148:713-719.	NULL
.	NULL

Baggiolini	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Walz	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
Kunkel	NULL
.	NULL

1989	NULL
.	NULL

Neutrophil-activating	NULL
pep-tide-l/interleukin	NULL
8	NULL
,	NULL
a	NULL
novel	NULL
cytokine	NULL
that	NULL
activates	NULL
neutrophils	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

84:1045-1049	NULL
.	NULL

9	NULL
.	NULL

Baruch	NULL
,	NULL
A.	NULL
,	NULL
D.	NULL
F.	NULL
Michiel	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
Oppenheim	NULL
.	NULL

1995	NULL
.	NULL

Signals	NULL
and	NULL
receptors	NULL
involved	NULL
in	NULL
recruitment	NULL
of	NULL
inflammatory	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:11703-11706	NULL
.	NULL

10	NULL
.	NULL

Baggiolini	NULL
,	NULL
M.	NULL
1998	NULL
.	NULL

Chemokines	NULL
and	NULL
leukocyte	NULL
traffic	NULL
.	NULL

Nature	NULL
392:565-568	NULL
.	NULL

11	NULL
.	NULL

Kunkel	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
T.	NULL
Standiford	NULL
,	NULL
K.	NULL
Kasahara	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Stricter	NULL
.	NULL

1991	NULL
.	NULL

Interleukin-8	NULL
(	NULL
IL-8	NULL
)	NULL
:	NULL
the	NULL
major	NULL
neutrophil	NULL
chemotactic	NULL
factor	NULL
in	NULL
the	NULL
lung	NULL
.	NULL

Exp	NULL
.	NULL

Lung	NULL
Res	NULL
.	NULL

17:17-23	NULL
.	NULL

12	NULL
.	NULL

Teran	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
S.	NULL
L.	NULL
Johnston	NULL
,	NULL
J.	NULL
M.	NULL
Schroder	NULL
,	NULL
M.	NULL
K.	NULL
Church	NULL
,	NULL
and	NULL
S.	NULL
T.	NULL
Hol-gate	NULL
.	NULL

1997	NULL
.	NULL

Role	NULL
of	NULL
nasal	NULL
interleukin-8	NULL
in	NULL
neutrophil	NULL
recruitment	NULL
and	NULL
activation	NULL
in	NULL
children	NULL
with	NULL
virus-induced	NULL
asthma	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Respir	NULL
.	NULL

Crit	NULL
.	NULL

Care	NULL
Med	NULL
.	NULL

155:1362-1366	NULL
.	NULL

13	NULL
.	NULL

Taub	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
Oppenheim	NULL
.	NULL

1994	NULL
.	NULL

Chemokines	NULL
,	NULL
inflammation	NULL
and	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Ther	NULL
.	NULL

Immunol	NULL
.	NULL

1:229-246	NULL
.	NULL

14	NULL
.	NULL

Stricter	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
K.	NULL
Kasahara	NULL
,	NULL
R.	NULL
M.	NULL
Allen	NULL
,	NULL
T.	NULL
J.	NULL
Standiford	NULL
,	NULL
M.	NULL
W.	NULL
Rolfe	NULL
,	NULL
F.	NULL
S.	NULL
Becker	NULL
,	NULL
S.	NULL
W.	NULL
Chensue	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
Kunkel	NULL
.	NULL

1992	NULL
.	NULL

Cytokine-induced	NULL
neutrophil-derived	NULL
interleukin-8	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

141:397-407	NULL
.	NULL

15	NULL
.	NULL

Fujishima	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
R.	NULL
Hoffman	NULL
,	NULL
T.	NULL
Vu	NULL
,	NULL
K.	NULL
J.	NULL
Kim	NULL
,	NULL
H.	NULL
Zheng	NULL
,	NULL
D.	NULL
Daniel	NULL
,	NULL
Y.	NULL
Kim	NULL
,	NULL
E.	NULL
F.	NULL
Wallace	NULL
,	NULL
J.	NULL
W.	NULL
Larrick	NULL
,	NULL
and	NULL
T.	NULL
A.	NULL
Raffin	NULL
.	NULL

1993	NULL
.	NULL

Regulation	NULL
of	NULL
neutrophil	NULL
interleukin	NULL
8	NULL
gene	NULL
expression	NULL
and	NULL
protein	NULL
secretion	NULL
by	NULL
LPS	NULL
,	NULL
TNF-	NULL
@	NULL
,	NULL
and	NULL
IL-1	NULL
8B	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

154:478-485	NULL
.	NULL

16	NULL
.	NULL

Cassatella	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
F.	NULL
Bazzoni	NULL
,	NULL
M.	NULL
Ceska	NULL
,	NULL
I.	NULL
Ferro	NULL
,	NULL
M.	NULL
Baggiolini	NULL
,	NULL
and	NULL
G.	NULL
Ber-ton	NULL
.	NULL

1992	NULL
.	NULL

IL-8	NULL
production	NULL
by	NULL
human	NULL
polymorphonuclear	NULL
leukocytes	NULL
:	NULL
the	NULL
chemoattractant	NULL
formyl-methionyl-leucyl-phenylalanine	NULL
induces	NULL
the	NULL
gene	NULL
expression	NULL
and	NULL
release	NULL
of	NULL
IL-8	NULL
through	NULL
a	NULL
pertussis	NULL
toxin-sensitive	NULL
pathway	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

148:3216-3220	NULL
.	NULL

17	NULL
.	NULL

McCain	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
E.	NULL
P.	NULL
Holden	NULL
,	NULL
T.	NULL
R.	NULL
Blackwell	NULL
,	NULL
and	NULL
J.	NULL
W.	NULL
Christman	NULL
.	NULL

1994	NULL
.	NULL

Leukotriene	NULL
B4	NULL
stimulates	NULL
human	NULL
polymorphonuclear	NULL
leukocytes	NULL
to	NULL
synthesize	NULL
and	NULL
release	NULL
interleukin-8	NULL
in	NULL
vitro	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Respir	NULL
.	NULL

Cell	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
:	NULL
651-657.	NULL
.	NULL

Browning	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
Z.	NULL
K.	NULL
Pan	NULL
,	NULL
E.	NULL
R.	NULL
Prossnitz	NULL
,	NULL
and	NULL
R.	NULL
D.	NULL
Ye	NULL
.	NULL

1997	NULL
.	NULL

Cell	NULL
type-and	NULL
developmental	NULL
stage-specific	NULL
activation	NULL
of	NULL
NF-kB	NULL
by	NULL
fMet-Leu-Phe	NULL
in	NULL
myeloid	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:7995-8001	NULL
.	NULL

19	NULL
.	NULL

Kita	NULL
,	NULL
H.	NULL
,	NULL
R.	NULL
I.	NULL
Abu-Ghazaleh	NULL
,	NULL
S.	NULL
Sur	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Gleich	NULL
.	NULL

1995	NULL
.	NULL

Eosinophil	NULL
major	NULL
basic	NULL
protein	NULL
induces	NULL
degranulation	NULL
and	NULL
IL-8	NULL
production	NULL
by	NULL
human	NULL
cosinophils	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154:4749-4758	NULL
.	NULL

20	NULL
.	NULL

Slifman	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
D.	NULL
A.	NULL
Loegering	NULL
,	NULL
D.	NULL
J.	NULL
McKean	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Gleich	NULL
.	NULL

1986	NULL
.	NULL

Ribonuclease	NULL
activity	NULL
associated	NULL
with	NULL
human	NULL
eosinophil-derived	NULL
neurotoxin	NULL
and	NULL
eosinophil	NULL
cationic	NULL
protein	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

137:2913-2917.	NULL
.	NULL

Carlson	NULL
,	NULL
M.	NULL
G.	NULL
C.	NULL
,	NULL
C.	NULL
G.	NULL
B.	NULL
Peterson	NULL
,	NULL
and	NULL
P.	NULL
Venge	NULL
.	NULL

1985	NULL
.	NULL

Human	NULL
cosino-phil	NULL
peroxidase	NULL
:	NULL
purification	NULL
and	NULL
characterization	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

134:1875-1879	NULL
.	NULL

22	NULL
.	NULL

Ten	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
L.	NULL
R.	NULL
Pease	NULL
,	NULL
D.	NULL
J.	NULL
McKean	NULL
,	NULL
M.	NULL
P.	NULL
Bell	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Gleich	NULL
.	NULL

1989.	NULL
ia	NULL
go	NULL
1	NULL
go	NULL
2	NULL
w	NULL
Page	NULL
,	NULL
Gleich	NULL
,	NULL
Roebuck	NULL
,	NULL
et	NULL
al	NULL
.	NULL

:	NULL
Stimulation	NULL
of	NULL
Neutrophil	NULL
IL-8	NULL
Production	NULL
23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

3	NULL
fa	NULL
32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
the	NULL
human	NULL
eosinophil	NULL
peroxidase	NULL
:	NULL
evidence	NULL
for	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
peroxidase	NULL
multigene	NULL
family	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

169:1757-1769	NULL
.	NULL

Haskell	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
J.	NULL
N.	NULL
Moy	NULL
,	NULL
G.	NULL
J.	NULL
Gleich	NULL
,	NULL
and	NULL
L.	NULL
L.	NULL
Thomas	NULL
.	NULL

1995	NULL
.	NULL

Analysis	NULL
of	NULL
signaling	NULL
events	NULL
associated	NULL
with	NULL
activation	NULL
of	NULL
neutrophil	NULL
superoxide	NULL
anion	NULL
production	NULL
by	NULL
eosinophil	NULL
granule	NULL
major	NULL
basic	NULL
protein	NULL
.	NULL

Blood	NULL
86:4627-4637	NULL
.	NULL

Lakshminarayanan	NULL
,	NULL
V.	NULL
,	NULL
D.	NULL
W.	NULL
Beno	NULL
,	NULL
R.	NULL
H.	NULL
Costa	NULL
,	NULL
and	NULL
K.	NULL
A.	NULL
Roebuck	NULL
.	NULL

1997	NULL
.	NULL

Differential	NULL
regulation	NULL
of	NULL
interleukin-8	NULL
and	NULL
intercellular	NULL
adhesion	NULL
mole-cule-1	NULL
by	NULL
H	NULL
,	NULL
O	NULL
;	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor-alpha	NULL
in	NULL
endothelial	NULL
and	NULL
epithelial	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:32910-32918	NULL
.	NULL

Osborn	NULL
,	NULL
L.	NULL
,	NULL
S.	NULL
Kunkel	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
and	NULL
interleukin	NULL
1	NULL
stimulate	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
enhancer	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
nuclear	NULL
factor-kB	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

A	NULL
cad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:2336-2340	NULL
.	NULL

McDonald	NULL
,	NULL
P.	NULL
P.	NULL
,	NULL
A.	NULL
Bald	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Cassatella	NULL
.	NULL

1997	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
NF-kB	NULL
pathway	NULL
by	NULL
inflammatory	NULL
stimuli	NULL
in	NULL
human	NULL
neutrophils	NULL
.	NULL

Blood	NULL
89	NULL
:	NULL
3421-3433	NULL
.	NULL

Zabucchi	NULL
,	NULL
G.	NULL
,	NULL
R.	NULL
Menegazzi	NULL
,	NULL
R.	NULL
Cramer	NULL
,	NULL
E.	NULL
Nardon	NULL
,	NULL
and	NULL
P.	NULL
Patriarca	NULL
.	NULL

1990	NULL
.	NULL

Mutual	NULL
influence	NULL
between	NULL
eosinophil	NULL
peroxidase	NULL
(	NULL
EPO	NULL
)	NULL
and	NULL
neutrophils	NULL
:	NULL
neutrophils	NULL
reversibly	NULL
inhibit	NULL
EPO	NULL
enzymatic	NULL
activity	NULL
and	NULL
EPO	NULL
increases	NULL
neutrophil	NULL
adhesiveness	NULL
.	NULL

Immunology	NULL
69:580-587	NULL
.	NULL

Ando	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
S.	NULL
Watanabe	NULL
.	NULL

1969	NULL
.	NULL

A	NULL
new	NULL
method	NULL
for	NULL
fractionation	NULL
of	NULL
protamine	NULL
and	NULL
the	NULL
amino	NULL
acid	NULL
sequences	NULL
of	NULL
salmine	NULL
and	NULL
three	NULL
compounds	NULL
of	NULL
iri-dine	NULL
.	NULL

Int	NULL
.	NULL

J.	NULL
Prot	NULL
.	NULL

Res	NULL
.	NULL

1:221-224	NULL
.	NULL

Mukaida	NULL
,	NULL
N.	NULL
,	NULL
S.	NULL
Okamoto	NULL
,	NULL
Y.	NULL
Ishikawa	NULL
,	NULL
and	NULL
K.	NULL
Matsushima	NULL
.	NULL

1994	NULL
.	NULL

Molecular	NULL
mechanism	NULL
of	NULL
interleukin-8	NULL
gene	NULL
expression	NULL
.	NULL

J.	NULL
Leukoc	NULL
.	NULL

Biol	NULL
.	NULL

56:554-558	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
A.	NULL
T.	NULL
Baldwin	NULL
.	NULL

1993	NULL
.	NULL

Distinct	NULL
mechanisms	NULL
of	NULL
regulation	NULL
of	NULL
the	NULL
IL-8	NULL
gene	NULL
involve	NULL
synergism	NULL
and	NULL
cooperativity	NULL
between	NULL
C/EBP	NULL
and	NULL
NF-	NULL
kB	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

13:7191-7198.	NULL
.	NULL

Matsusaka	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Fujikawa	NULL
,	NULL
Y.	NULL
Nishio	NULL
,	NULL
N.	NULL
Mukaida	NULL
,	NULL
K.	NULL
Matsushima	NULL
,	NULL
T.	NULL
Kishimoto	NULL
,	NULL
and	NULL
S.	NULL
Akira	NULL
.	NULL

1993	NULL
.	NULL

Transcription	NULL
factors	NULL
NF-IL6	NULL
and	NULL
NF-kB	NULL
synergistically	NULL
activate	NULL
transcription	NULL
of	NULL
the	NULL
inflammatory	NULL
cytokines	NULL
,	NULL
inter-leukin-6	NULL
and	NULL
interleukin-8	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

A	NULL
cad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:10193-10197	NULL
.	NULL

Hachicha	NULL
,	NULL
M.	NULL
,	NULL
P.	NULL
Rathanaswami	NULL
,	NULL
P.	NULL
H.	NULL
Naccache	NULL
,	NULL
and	NULL
S.	NULL
R.	NULL
McColl	NULL
.	NULL

1998	NULL
.	NULL

Regulation	NULL
of	NULL
chemokine	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
neutrophils	NULL
phagocytosing	NULL
microbial	NULL
pathogens	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160:449-454	NULL
.	NULL

Frigas	NULL
,	NULL
E.	NULL
,	NULL
D.	NULL
A.	NULL
Locgering	NULL
,	NULL
G.	NULL
O.	NULL
Solley	NULL
,	NULL
G.	NULL
M.	NULL
Farrow	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Gleich	NULL
.	NULL

1981	NULL
.	NULL

Elevated	NULL
levels	NULL
of	NULL
the	NULL
eosinophil	NULL
granule	NULL
major	NULL
basic	NULL
protein	NULL
in	NULL
the	NULL
sputum	NULL
of	NULL
patients	NULL
with	NULL
bronchial	NULL
asthma	NULL
.	NULL

Mayo	NULL
Clin	NULL
.	NULL

Proc	NULL
.	NULL

56:345-353	NULL
.	NULL

Abu-Ghazaleh	NULL
,	NULL
R.	NULL
F.	NULL
,	NULL
S.	NULL
L.	NULL
Dunnette	NULL
,	NULL
D.	NULL
A.	NULL
Loegering	NULL
,	NULL
J.	NULL
L.	NULL
Checkel	NULL
,	NULL
H.	NULL
Kita	NULL
,	NULL
L.	NULL
L.	NULL
Thomas	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Gleich	NULL
.	NULL

1992	NULL
.	NULL

Eosinophil	NULL
granule	NULL
proteins	NULL
in	NULL
peripheral	NULL
blood	NULL
granulocytes	NULL
.	NULL

J.	NULL
Leukoc	NULL
.	NULL

Biol	NULL
.	NULL

52:611-618	NULL
.	NULL

Henderson	NULL
,	NULL
W.	NULL
R.	NULL
,	NULL
E.	NULL
Y.	NULL
Chi	NULL
,	NULL
and	NULL
S.	NULL
J.	NULL
Klebanoff	NULL
.	NULL

1980	NULL
.	NULL

Eosinophil	NULL
peroxi-dase-induced	NULL
mast	NULL
cell	NULL
secretion	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

152:265-279	NULL
.	NULL

Klebanoff	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
J.	NULL
M.	NULL
A	NULL
gosti	NULL
,	NULL
A.	NULL
Jorg	NULL
,	NULL
and	NULL
A.	NULL
M.	NULL
Waltersdorph	NULL
.	NULL

1989	NULL
.	NULL

Comparative	NULL
toxicity	NULL
of	NULL
the	NULL
horse	NULL
eosinophil	NULL
peroxidase-H,0	NULL
;	NULL
-halide	NULL
system	NULL
and	NULL
granule	NULL
basic	NULL
proteins	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

143:239-244	NULL
.	NULL

Mayeno	NULL
,	NULL
A.	NULL
N.	NULL
,	NULL
A.	NULL
J.	NULL
Curran	NULL
,	NULL
R.	NULL
L.	NULL
Roberts	NULL
,	NULL
and	NULL
C.	NULL
S.	NULL
Foote	NULL
.	NULL

1989	NULL
.	NULL

Eosinophils	NULL
preferentially	NULL
use	NULL
bromide	NULL
to	NULL
generate	NULL
halogenating	NULL
agents	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264:5660-5668	NULL
.	NULL

Furuta	NULL
,	NULL
G.	NULL
T.	NULL
,	NULL
S.	NULL
J.	NULL
Ackerman	NULL
,	NULL
L.	NULL
Lu	NULL
,	NULL
R.	NULL
E.	NULL
Williams	NULL
,	NULL
and	NULL
B.	NULL
K.	NULL
Wershil	NULL
.	NULL

1998	NULL
.	NULL

Stem	NULL
cell	NULL
factor	NULL
influences	NULL
mast	NULL
cell	NULL
mediator	NULL
release	NULL
in	NULL
response	NULL
to	NULL
eosinophil-derived	NULL
granule	NULL
major	NULL
basic	NULL
protein	NULL
.	NULL

Blood	NULL
92:1055-1061	NULL
.	NULL

Sugita	NULL
,	NULL
N.	NULL
,	NULL
A.	NULL
Kimura	NULL
,	NULL
Y.	NULL
Matsuki	NULL
,	NULL
T.	NULL
Yamamoto	NULL
,	NULL
H.	NULL
Yoshie	NULL
,	NULL
and	NULL
K.	NULL
Hara	NULL
.	NULL

1998	NULL
.	NULL

Activation	NULL
of	NULL
transcription	NULL
factors	NULL
and	NULL
IL-8	NULL
expression	NULL
in	NULL
neutrophils	NULL
stimulated	NULL
with	NULL
lipopolysaccharide	NULL
from	NULL
Porphyromonas	NULL
gingivalis	NULL
.	NULL

Inflammation	NULL
22:253-267	NULL
.	NULL

Kuhns	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
H.	NULL
A	NULL
.	NULL

Young	NULL
,	NULL
E.	NULL
K.	NULL
Gallin	NULL
,	NULL
and	NULL
J.	NULL
I.	NULL
Gallin	NULL
.	NULL

1998	NULL
.	NULL

Ca**-depen-dent	NULL
production	NULL
and	NULL
release	NULL
of	NULL
IL-8	NULL
in	NULL
human	NULL
neutrophils	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

16124332-4339	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

5	NULL
go	NULL
237	NULL
Wu	NULL
,	NULL
G.	NULL
D.	NULL
,	NULL
E.	NULL
J.	NULL
Lai	NULL
,	NULL
N.	NULL
Huang	NULL
,	NULL
and	NULL
X.	NULL
Wen	NULL
.	NULL

1997	NULL
.	NULL

Oct-1	NULL
and	NULL
CCAAT/en-hancer-binding	NULL
protein	NULL
(	NULL
C/EBP	NULL
)	NULL
bind	NULL
to	NULL
overlapping	NULL
elements	NULL
within	NULL
the	NULL
interleukin-8	NULL
promoter	NULL
.	NULL

The	NULL
role	NULL
of	NULL
Oct-1	NULL
as	NULL
a	NULL
transcriptional	NULL
repressor	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:2396-2403	NULL
.	NULL

Stoeckle	NULL
,	NULL
M.	NULL
Y	NULL
.	NULL

1991	NULL
.	NULL

Post-transcriptional	NULL
regulation	NULL
of	NULL
grow	NULL
,	NULL
B	NULL
,	NULL
y	NULL
,	NULL
and	NULL
IL-8	NULL
mRNAs	NULL
by	NULL
IL-1	NULL
B.	NULL
Nucleic	NULL
A	NULL
cids	NULL
Res	NULL
.	NULL

19:917-920	NULL
.	NULL

Abruzzo	NULL
,	NULL
L.	NULL
V.	NULL
,	NULL
A.	NULL
J.	NULL
Thornton	NULL
,	NULL
M.	NULL
Licbert	NULL
,	NULL
H.	NULL
B.	NULL
Grossman	NULL
,	NULL
H.	NULL
Evanoff	NULL
,	NULL
J.	NULL
Westwick	NULL
,	NULL
R.	NULL
M.	NULL
Stricter	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
Kunkel	NULL
.	NULL

1992	NULL
.	NULL

Cytokine-induced	NULL
gene	NULL
expression	NULL
of	NULL
interleukin-8	NULL
in	NULL
human	NULL
transitional	NULL
cell	NULL
carcinomas	NULL
and	NULL
renal	NULL
cell	NULL
carcinomas	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

140:365-373	NULL
.	NULL

Bosco	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
G.	NULL
L.	NULL
Gusella	NULL
,	NULL
I.	NULL
Espinoza-Delgado	NULL
,	NULL
D.	NULL
L.	NULL
Longo	NULL
,	NULL
and	NULL
L..	NULL
Vare-sio	NULL
.	NULL

1994	NULL
.	NULL

Interferon-y	NULL
upregulates	NULL
interleukin-8	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
monocytic	NULL
cells	NULL
by	NULL
a	NULL
posttranscriptional	NULL
mechanism	NULL
.	NULL

Blood	NULL
83:537-542	NULL
.	NULL

Yu	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
K.	NULL
Chadee	NULL
.	NULL

1998	NULL
.	NULL

Prostaglandin	NULL
E2	NULL
stimulates	NULL
IL-8	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
colonic	NULL
epithelial	NULL
cells	NULL
by	NULL
a	NULL
posttranscriptional	NULL
mechanism	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:3746-3752	NULL
.	NULL

Jacobson	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
S.	NULL
W.	NULL
Peltz	NULL
.	NULL

1996	NULL
.	NULL

Interrelationships	NULL
of	NULL
the	NULL
pathways	NULL
of	NULL
mRNA	NULL
decay	NULL
and	NULL
translation	NULL
in	NULL
eukaryotic	NULL
cells	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

65	NULL
:	NULL
693-739	NULL
.	NULL

Malter	NULL
,	NULL
J.	NULL
S.	NULL
1989	NULL
.	NULL

Identification	NULL
of	NULL
an	NULL
AUUUA-specific	NULL
messenger	NULL
RNA	NULL
binding	NULL
protein	NULL
.	NULL

Science	NULL
246:664-666	NULL
.	NULL

Gillis	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
J.	NULL
S.	NULL
Malter	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
adenosine-uridine	NULL
binding	NULL
factor	NULL
recognizes	NULL
the	NULL
AU-rich	NULL
elements	NULL
of	NULL
cytokine	NULL
,	NULL
lymphokine	NULL
,	NULL
and	NULL
oncogene	NULL
mRNAs	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:3172-3177	NULL
.	NULL

Roger	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Out	NULL
,	NULL
N.	NULL
Mukaida	NULL
,	NULL
K.	NULL
Matsushima	NULL
,	NULL
H.	NULL
Jansen	NULL
,	NULL
and	NULL
R.	NULL
Lutter	NULL
.	NULL

1998	NULL
.	NULL

Enhanced	NULL
AP-1	NULL
and	NULL
NF-kB	NULL
activities	NULL
and	NULL
stability	NULL
of	NULL
interleukin	NULL
8	NULL
(	NULL
IL-8	NULL
)	NULL
transcripts	NULL
are	NULL
implicated	NULL
in	NULL
IL-8	NULL
mRNA	NULL
superinduction	NULL
in	NULL
lung	NULL
epithelial	NULL
H292	NULL
cells	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

330:429-435	NULL
.	NULL

Cassatella	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
I.	NULL
Guasparri	NULL
,	NULL
M.	NULL
Ceska	NULL
,	NULL
F.	NULL
Bazzoni	NULL
,	NULL
and	NULL
F.	NULL
Rossi	NULL
.	NULL

1993	NULL
.	NULL

In-terferon-gamma	NULL
inhibits	NULL
interleukin-8	NULL
production	NULL
by	NULL
human	NULL
polymorphonuclear	NULL
leucocytes	NULL
.	NULL

Immunology	NULL
78:177-184	NULL
.	NULL

Kasama	NULL
,	NULL
T.	NULL
,	NULL
R.	NULL
M.	NULL
Stricter	NULL
,	NULL
N.	NULL
W.	NULL
Lukacs	NULL
,	NULL
M.	NULL
D.	NULL
Burdick	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
Kunkel	NULL
.	NULL

1994	NULL
.	NULL

Regulation	NULL
of	NULL
neutrophil-derived	NULL
chemokine	NULL
expression	NULL
by	NULL
IL-10	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

152:3559-3569	NULL
.	NULL

Wang	NULL
,	NULL
P.	NULL
,	NULL
P.	NULL
Wu	NULL
,	NULL
J.	NULL
C.	NULL
Anthes	NULL
,	NULL
M.	NULL
I.	NULL
Siegel	NULL
,	NULL
R.	NULL
W.	NULL
Egan	NULL
,	NULL
and	NULL
M.	NULL
M.	NULL
Billah	NULL
.	NULL

1994	NULL
.	NULL

Interleukin-10	NULL
inhibits	NULL
interleukin-8	NULL
production	NULL
in	NULL
human	NULL
neutrophils	NULL
.	NULL

Blood	NULL
83:2678-2683.	NULL
.	NULL

Larsen	NULL
,	NULL
C.	NULL
G.	NULL
,	NULL
A.	NULL
O.	NULL
Anderson	NULL
,	NULL
E.	NULL
Appella	NULL
,	NULL
J.	NULL
J.	NULL
Oppenheim	NULL
,	NULL
and	NULL
K.	NULL
Mat	NULL
sushima	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
neutrophil-activating	NULL
protein	NULL
(	NULL
NAP-1	NULL
)	NULL
is	NULL
also	NULL
chemotactic	NULL
for	NULL
T	NULL
lymphocytes	NULL
.	NULL

Science	NULL
243:1464-1466	NULL
.	NULL

Schweizer	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Welmers	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Raaijmakers	NULL
,	NULL
P.	NULL
Zanen	NULL
,	NULL
J.	NULL
W.	NULL
Lam-mers	NULL
,	NULL
and	NULL
L.	NULL
Koenderman	NULL
.	NULL

1994	NULL
.	NULL

RANTES-	NULL
and	NULL
interleukin-8-induced	NULL
responses	NULL
in	NULL
normal	NULL
human	NULL
eosinophils	NULL
:	NULL
effects	NULL
of	NULL
priming	NULL
with	NULL
interleukin-5	NULL
.	NULL

Blood	NULL
$	NULL
3:3697-3704	NULL
.	NULL

Dahinden	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Y.	NULL
Kurimoto	NULL
,	NULL
A.	NULL
L.	NULL
De	NULL
Week	NULL
,	NULL
I.	NULL
Lindley	NULL
,	NULL
B.	NULL
Dewald	NULL
,	NULL
and	NULL
M.	NULL
Baggiolini	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
neutrophil-activating	NULL
peptide	NULL
NAF/NAP-1	NULL
induces	NULL
histamine	NULL
and	NULL
leukotriene	NULL
release	NULL
by	NULL
interleukin	NULL
3-primed	NULL
baso-phils	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

170:1787-1792	NULL
.	NULL

Lippert	NULL
,	NULL
U.	NULL
,	NULL
M.	NULL
Artuc	NULL
,	NULL
A.	NULL
Grutzkau	NULL
,	NULL
A.	NULL
Moller	NULL
,	NULL
A.	NULL
Kenderessy-Szabo	NULL
,	NULL
D.	NULL
Schadendorf	NULL
,	NULL
J.	NULL
Norgauer	NULL
,	NULL
K.	NULL
Hartmann	NULL
,	NULL
R.	NULL
Schweitzer-Stenner	NULL
,	NULL
T.	NULL
Zuber-bier	NULL
,	NULL
B.	NULL
M.	NULL
Henz	NULL
,	NULL
and	NULL
S.	NULL
Kruger-Krasagakes	NULL
.	NULL

1998	NULL
.	NULL

Expression	NULL
and	NULL
functional	NULL
activity	NULL
of	NULL
the	NULL
IL-8	NULL
receptor	NULL
type	NULL
CXCR1	NULL
and	NULL
CXCR2	NULL
on	NULL
human	NULL
mast	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:2600-2608	NULL
.	NULL

Henson	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
and	NULL
R.	NULL
B.	NULL
Johnston	NULL
,	NULL
Jr.	NULL
1987	NULL
.	NULL

Tissue	NULL
injury	NULL
in	NULL
inflammation	NULL
:	NULL
oxidants	NULL
,	NULL
proteinases	NULL
,	NULL
and	NULL
cationic	NULL
proteins	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

79:669-674.	NULL
.	NULL

Sactta	NULL
,	NULL
M.	NULL
,	NULL
A	NULL
.	NULL

Di	NULL
Stefano	NULL
,	NULL
P.	NULL
Maestrelli	NULL
,	NULL
G.	NULL
Turato	NULL
,	NULL
M.	NULL
P.	NULL
Ruggieri	NULL
,	NULL
A.	NULL
Rog-	NULL
geri	NULL
,	NULL
P.	NULL
Calcagni	NULL
,	NULL
C.	NULL
E.	NULL
Mapp	NULL
,	NULL
A.	NULL
Ciaccia	NULL
,	NULL
and	NULL
L.	NULL
M.	NULL
Fabbri	NULL
.	NULL

1994	NULL
.	NULL

Airway	NULL
eosinophilia	NULL
in	NULL
chronic	NULL
bronchitis	NULL
during	NULL
exacerbations	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Respir	NULL
Crit	NULL
.	NULL

Care	NULL
Med	NULL
.	NULL

150:1646-1652	NULL
.	NULL

